<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">89705</article-id><article-id pub-id-type="doi">10.7554/eLife.89705</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.89705.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>An anciently diverged family of RNA binding proteins maintain correct splicing of a class of ultra-long exons through cryptic splice site repression</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Siachisumo</surname><given-names>Chileleko</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name><surname>Luzzi</surname><given-names>Sara</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6337-7495</contrib-id><email>Sara.Luzzi@newcastle.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Aldalaqan</surname><given-names>Saad</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Hysenaj</surname><given-names>Gerald</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Dalgliesh</surname><given-names>Caroline</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Cheung</surname><given-names>Kathleen</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Gazzara</surname><given-names>Matthew R</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Yonchev</surname><given-names>Ivaylo D</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>James</surname><given-names>Katherine</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kheirollahi Chadegani</surname><given-names>Mahsa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ehrmann</surname><given-names>Ingrid E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Graham R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Cockell</surname><given-names>Simon J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6831-9806</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Munkley</surname><given-names>Jennifer</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Stuart A</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Barash</surname><given-names>Yoseph</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Elliott</surname><given-names>David J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6930-0699</contrib-id><email>David.Elliott@ncl.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01kj2bm70</institution-id><institution>Biosciences Institute, Faculty of Medical Sciences, Newcastle University</institution></institution-wrap><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01kj2bm70</institution-id><institution>Bioinformatics Support Unit, Faculty of Medical Sciences, Newcastle University</institution></institution-wrap><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00b30xv10</institution-id><institution>Department of Genetics, Perelman School of Medicine, University of Pennsylvania</institution></institution-wrap><addr-line><named-content content-type="city">Phildelphia</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05krs5044</institution-id><institution>School of Biosciences, University of Sheffield</institution></institution-wrap><addr-line><named-content content-type="city">Sheffield</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01kj2bm70</institution-id><institution>School of Computing, Newcastle University</institution></institution-wrap><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ron</surname><given-names>David</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>University of Cambridge</institution></institution-wrap><country>United Kingdom</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Ron</surname><given-names>David</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>University of Cambridge</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>02</day><month>10</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP89705</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-07-14"><day>14</day><month>07</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-08-15"><day>15</day><month>08</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.08.15.553384"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-10-02"><day>02</day><month>10</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89705.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-08-13"><day>13</day><month>08</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.89705.2"/></event></pub-history><permissions><copyright-statement>© 2023, Siachisumo, Luzzi, Aldalaqan et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Siachisumo, Luzzi, Aldalaqan et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-89705-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-89705-figures-v1.pdf"/><related-article related-article-type="article-reference" ext-link-type="doi" xlink:href="10.7554/elife.39304" id="ra1"/><abstract><p>Previously, we showed that the germ cell-specific nuclear protein RBMXL2 represses cryptic splicing patterns during meiosis and is required for male fertility (Ehrmann et al., 2019). Here, we show that in somatic cells the similar yet ubiquitously expressed RBMX protein has similar functions. RBMX regulates a distinct class of exons that exceed the median human exon size. RBMX protein-RNA interactions are enriched within ultra-long exons, particularly within genes involved in genome stability, and repress the selection of cryptic splice sites that would compromise gene function. The <italic>RBMX</italic> gene is silenced during male meiosis due to sex chromosome inactivation. To test whether RBMXL2 might replace the function of RBMX during meiosis we induced expression of RBMXL2 and the more distantly related RBMY protein in somatic cells, finding each could rescue aberrant patterns of RNA processing caused by RBMX depletion. The C-terminal disordered domain of RBMXL2 is sufficient to rescue proper splicing control after RBMX depletion. Our data indicate that RBMX and RBMXL2 have parallel roles in somatic tissues and the germline that must have been conserved for at least 200 million years of mammalian evolution. We propose RBMX family proteins are particularly important for the splicing inclusion of some ultra-long exons with increased intrinsic susceptibility to cryptic splice site selection.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>RNA</kwd><kwd>Splicing</kwd><kwd>gene expression</kwd><kwd>exon</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000268</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><award-id>BB/S008039/1</award-id><principal-award-recipient><name><surname>Dalgliesh</surname><given-names>Caroline</given-names></name><name><surname>Elliott</surname><given-names>David J</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000268</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><award-id>BB/W002019/1</award-id><principal-award-recipient><name><surname>Luzzi</surname><given-names>Sara</given-names></name><name><surname>Dalgliesh</surname><given-names>Caroline</given-names></name><name><surname>Ehrmann</surname><given-names>Ingrid E</given-names></name><name><surname>Elliott</surname><given-names>David J</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000268</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><award-id>Newcastle Liverpool Durham BBSRC Doctoral Training Partnership (BB/M011186/1)</award-id><principal-award-recipient><name><surname>Siachisumo</surname><given-names>Chileleko</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000268</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><award-id>BB/P006612/1</award-id><principal-award-recipient><name><surname>Ehrmann</surname><given-names>Ingrid E</given-names></name><name><surname>Elliott</surname><given-names>David J</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>King Fahad Medical City</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Aldalaqan</surname><given-names>Saad</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A family of RNA binding proteins that diverged 200 million years ago have parallel roles in protecting the transcriptomic integrity of ultra-long exons within their respective cell types.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Efficient gene expression in eukaryotes requires introns and exons to be correctly recognised by the spliceosome, the macromolecular machine that joins exons together. The spliceosome recognises short sequences called splice sites that are present at exon-intron junctions within precursor mRNAs. In higher organisms, there is some flexibility in splice site recognition, as most genes produce multiple mRNAs by alternative splicing. However, aberrant ‘cryptic’ splice sites that are weakly selected or totally ignored by the spliceosome occur frequently in the human genome and can function as decoys to interfere with gene expression (<xref ref-type="bibr" rid="bib2">Aldalaqan et al., 2022</xref>; <xref ref-type="bibr" rid="bib45">Sibley et al., 2016</xref>). Many cryptic splice sites are located amongst repetitive sequences within introns, where they are repressed by RNA-binding proteins belonging to the hnRNP family (<xref ref-type="bibr" rid="bib4">Attig et al., 2018</xref>). However, cryptic splice sites can also be present within exons, and particularly can shorten long exons (by providing competing alternative splice sites) or cause the formation of exitrons (internal exon sequences that are removed as if they were introns) (<xref ref-type="bibr" rid="bib36">Marquez et al., 2015</xref>).</p><p>The testis-specific nuclear RNA binding protein RBMXL2 was recently shown to repress cryptic splice site selection during meiosis, including within some ultra-long exons of genes involved in genome stability (<xref ref-type="bibr" rid="bib15">Ehrmann et al., 2019</xref>). RBMXL2 is only expressed within the testis (<xref ref-type="bibr" rid="bib2">Aldalaqan et al., 2022</xref>; <xref ref-type="bibr" rid="bib15">Ehrmann et al., 2019</xref>), raising the question of how these same cryptic splice sites controlled by RBMXL2 are repressed in other parts of the body. Suggesting a possible answer to this question, RBMXL2 is part of an anciently diverged family of RNA-binding proteins. The <italic>RBMXL2</italic> gene evolved 65 million years ago following retro-transposition of the <italic>RBMX</italic> gene from the X chromosome to an autosome (<xref ref-type="bibr" rid="bib15">Ehrmann et al., 2019</xref>). RBMX and RBMXL2 proteins (also known as hnRNP-G and hnRNP-GT) share 73% identity at the protein level and have the same modular structure comprising an N-terminal RNA recognition motif (RRM) and a C-terminal disordered region containing RGG repeats (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). RBMX and RBMXL2 are also more distantly related to a gene called <italic>RBMY</italic> on the long arm of the Y chromosome that is deleted in some infertile men (with only ~37% identity between human RBMXL2 and RBMY) (<xref ref-type="bibr" rid="bib16">Elliott et al., 1997</xref>; <xref ref-type="bibr" rid="bib35">Ma et al., 1993</xref>). The role of RBMY in the germline is almost totally unknown, but RBMY protein has been implicated in splicing regulation (<xref ref-type="bibr" rid="bib17">Elliott et al., 2000</xref>; <xref ref-type="bibr" rid="bib55">Venables et al., 2000</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>RBMX primarily operates as a splicing repressor in human somatic cells.</title><p>(<bold>A</bold>) Schematic structure of RBMX family proteins (left side, cladogram) and amino acid similarity of each domain between RBMX protein and two other members of this family, RBMXL2 and RBMY. RRM, RNA recognition motif; CD, central domain important for recognition of nascent transcripts and nuclear localisation; CTD, C-terminal domain, involved in RNA binding (<xref ref-type="bibr" rid="bib18">Elliott et al., 2019</xref>). (<bold>B</bold>) Western blot analysis shows efficient siRNA-mediated depletion of RBMX from MDA-MB-231 cells (each lane contains biologically independent replicate, apart from lane 4 which contained size markers). (<bold>C</bold>) Pie chart showing the percentages of events controlled by RBMX in both MDA-MB-231 (this study) and HEK293 (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>) cells. (<bold>D</bold>) Pie chart showing the percentages of events controlled by RBMX in both MDA-MB-231 and HEK293 cells that have been previously annotated (Refseq, Ensembl, Gencode), and those that are novel to this study. (<bold>E</bold>) Bar chart showing the different types of alternative splicing events controlled by RBMX protein in both HEK293 and MDA-MB-231 cells, summarising the proportion of splicing events that are activated by RBMX versus those that are repressed. (<bold>F</bold>) Splice site score analyses for 5ʹ (left panel) and 3ʹ (right panel) splice sites repressed by RBMX compared to RBMX non-responsive alternative splice sites. eCDF, empirical Cumulative Distribution Function. Two-sample KS test two-sided p-value = 0.41 and 0.33, respectively.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>List of splicing defects in MDA-MB-231 and HEK293 related to <xref ref-type="fig" rid="fig1">Figure 1C</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89705-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89705-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Splicing patterns controlled by RBMX within MDA-MB-231 cells and splice site strengths of exons activated by RBMX.</title><p>(<bold>A</bold>) Bar chart showing the different types of alternative splicing events controlled by RBMX protein in MDA-MB-231 cells, summarising the proportion of splicing events that are activated by RBMX versus those that are repressed. (<bold>B</bold>) Splice site score analyses for 5ʹ (left panel) and 3ʹ (right panel) splice sites activated by RBMX compared to RBMX their non-responsive alternative splice sites. eCDF, empirical Cumulative Distribution Function. Two-sample KS test two-sided p-value = 0.23 and 0.0007 (**), respectively.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89705-fig1-figsupp1-v1.tif"/></fig></fig-group><p>The location of <italic>RBMX</italic> and <italic>RBMY</italic> on the X and Y chromosomes has important implications for their expression patterns during meiosis. The X and Y chromosomes are inactivated during meiosis within a heterochromatic structure called the XY body (<xref ref-type="bibr" rid="bib50">Turner, 2015</xref>; <xref ref-type="bibr" rid="bib56">Wang, 2004</xref>). Meiosis is quite a long process, and to maintain cell viability during this extended period a number of autosomal retrogenes have evolved from essential X chromosome genes. These autosomal retrogenes are actively expressed during meiosis when the X chromosome is inactive. However, it is unknown whether RBMXL2 is functionally similar enough to RBMX to provide a direct replacement during meiosis, or whether RBMXL2 has evolved differently to control meiosis-specific patterns of expression. Suggesting somewhat different activities, RBMX was recently shown to activate exon splicing inclusion, via a mechanism involving binding to RNA through its C-terminal disordered domain facilitated by recognition of m6A residues and RNA polymerase II pausing (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib62">Zhou et al., 2019</xref>).</p><p>Here, we have used iCLIP and RNA-seq to analyse the binding characteristics and RNA processing targets of human RBMX. We identify a novel class of RBMX-dependent ultra-long exons connected to genome stability and transcriptional control, and find that RBMX, RBMXL2, and RBMY paralogs have closely related functional activity in repressing cryptic splice site selection. Our data reveal an ancient mechanism of gene expression control by RBMX family proteins that predates the radiation of mammals, and provides a new understanding of how ultra-long exons are properly incorporated into mRNAs.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>RBMX primarily operates as a splicing repressor in somatic cells</title><p>We first set out to identify the spectrum of splicing events that are strongly controlled by RBMX across different human cell lines. We used RNA-seq from biological triplicate MDA-MB-231 cells treated with siRNA against RBMX (achieving &gt;90% depletion, <xref ref-type="fig" rid="fig1">Figure 1B</xref>), followed by bioinformatics analysis using the SUPPA2 (<xref ref-type="bibr" rid="bib49">Trincado et al., 2018</xref>) and MAJIQ (<xref ref-type="bibr" rid="bib54">Vaquero-Garcia et al., 2023</xref>; <xref ref-type="bibr" rid="bib53">Vaquero-Garcia et al., 2016</xref>) splicing prediction tools. We identified 315 changes in RNA processing patterns in response to RBMX-depletion that were of high enough amplitude to be visually confirmed on the IGV genome browser (<xref ref-type="bibr" rid="bib43">Robinson et al., 2011</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>; <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>). Analysis of these splicing events within existing RNA-seq data from HEK293 cells depleted for RBMX (GSE74085) (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>) revealed 148 high amplitude events that are controlled by RBMX in both HEK293 and MDA-MB-231 cells (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). We concentrated our downstream analysis on these splicing events (<xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>). 92% of the splicing events regulated by RBMX in human somatic cells were already annotated on Ensembl, Gencode or Refseq (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Strikingly two-thirds of these events are repressed by RBMX, meaning they were increasingly used in RBMX-depleted cells compared to control, and include exon inclusion, alternative 5ʹ and 3ʹ splice sites, exitrons, and intron retention (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Furthermore, analysis of splice site strength revealed that, unlike splice sites activated by RBMX (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>), alternative splice sites repressed by RBMX have comparable strength to more commonly used splice sites (<xref ref-type="fig" rid="fig1">Figure 1F</xref>). This means that RBMX operates as a splicing repressor in human somatic cells to prevent the use of ‘decoy’ splice sites that could disrupt normal patterns of gene expression.</p></sec><sec id="s2-2"><title>Splicing control and sites of RBMX protein-RNA interaction are enriched within long internal exons</title><p>The above data indicated that RBMX has a major role in repressing cryptic splicing patterns in human somatic cells. To further correlate splicing regulation to patterns of RBMX protein-RNA interactions, we next mapped the distribution of RBMX-RNA binding sites in human somatic cells. We engineered a stable human HEK293 cell line to express RBMX-FLAG fusion protein in response to tetracycline addition. Western blotting showed that expression of RBMX-FLAG was efficiently induced after tetracycline treatment. Importantly, levels of the induced RBMX-FLAG protein were similar to those of endogenous RBMX (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We next used this inducible cell line to carry out individual nucleotide resolution crosslinking and immunoprecipitation (iCLIP) – a technique that produces a global picture of protein-RNA binding sites (<xref ref-type="bibr" rid="bib30">Konig et al., 2011</xref>). After crosslinking, RBMX-FLAG protein was immunoprecipitated, then infra-red labeled RNA-protein adducts were isolated (<xref ref-type="fig" rid="fig2">Figure 2B</xref>) and subjected to library preparation. Following deep sequencing of biological triplicate experiments, 5–10 million unique reads (referred to here as iCLIP tags, representing sites of RBMX protein-RNA cross-linking) were aligned to the human genome. Each individual iCLIP replicate showed at least 70% correlation with each of the others (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). K-mer motif analysis revealed RBMX preferentially binds to AG-rich sequences (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Splicing control and sites of RBMX protein-RNA interaction are enriched within long internal exons.</title><p>(<bold>A</bold>) Western blot showing levels of RBMX-FLAG protein, expressed after 24 hr treatment with tetracycline, compared to endogenous RBMX within HEK293 cells, both detected using α-RBMX antibody. α-GAPDH antibody was used as a loading control. Each lane corresponds to a biologically independent replicate sample. (<bold>B</bold>) RNAs cross-linked to RBMX-FLAG during individual nucleotide resolution crosslinking and immunoprecipitation (iCLIP) were detected through the infrared adaptor (RBMX-RNA complexes). Lane 1, anti-FLAG pull-down from crosslinked HEK293 control cells not expressing RBMX-FLAG proteins, treated with 0.8 U/ml RNaseI. Lane 3, RBMX-FLAG pull-down crosslinked to RNA, treated with 2.5 U/ml RNaseI. Lanes 5–7, RBMX-FLAG pull-down crosslinked to RNA, treated with 0.8 U/ml RNaseI. Samples in lanes 5–7 were used for iCLIP library preparation. Lanes 2 and 4 are empty. (<bold>C</bold>) K-mer analysis shows the top 10 enriched motifs within sequences surrounding RBMX iCLIP tags. (<bold>D</bold>) Boxplot analysis shows sizes of exons containing splicing events regulated by RBMX, grouped by whether they contain CLIP tags or not. ****, p&lt;0.0001 (Mann-Whitney test). (<bold>E</bold>) Boxplot analysis shows the distribution of exon sizes relative to: all or internal exons contained in mRNA genes expressed in HEK293 cells (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>); exons regulated by RBMX as identified by RNA-seq; exons containing RBMX binding sites as identified by iCLIP, listed independently of iCLIP tag density. Median sizes for each group are shown. ****, p&lt;0.0001 (Wilcoxon rank test and Kruskal-Wallis test). (<bold>F</bold>) Distribution plot of exon sizes for the groups shown in (<bold>E</bold>). Note the increased accumulation of exons larger than 1000 bp (ultra-long exons) in RBMX-bound and regulated exons compared to all exons expressed in HEK293 (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>). (<bold>G</bold>) Bar plot indicating the proportion of ultra-long exons in the groups shown in (<bold>E, F</bold>). ****, p&lt;0.0001 (Chi-squared test). (<bold>H</bold>) Histogram of hexamer Z-scores for ultra-long exons (exceeding 1000 nt) versus non-ultra-long exons from Ensembl canonical mRNA transcripts. The top five enriched hexamers are shown with corresponding Z-scores. Grey dots indicate histogram bins containing one of the top 25 RBMX iCLIP hexamer motifs. (<bold>I</bold>) Similar analysis as in (<bold>H</bold>), but for ultra-long exons with evidence of RBMX binding or regulation versus RBMX-independent ultra-long exons.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>List of splicing defects with nearby RBMX CLIP tags from HEK293 cells related to <xref ref-type="fig" rid="fig2">Figure 2D</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89705-fig2-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>List of exons analysed in <xref ref-type="fig" rid="fig2">Figure 2E–G</xref>.</title></caption><media mimetype="text" mime-subtype="plain" xlink:href="elife-89705-fig2-data2-v1.txt"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89705-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Further analysis of RBMX protein-RNA interactions.</title><p>(<bold>A</bold>) Correlation analysis between three replicates for RBMX-FLAG iCLIP. (<bold>B</bold>) K-mer analysis shows the top 50 enriched motifs within sequences surrounding RBMX individual nucleotide resolution crosslinking and immunoprecipitation (iCLIP) binding. (<bold>C</bold>) Barplot showing the percentage of exons regulated by RBMX that contain iCLIP tags. (<bold>D</bold>) Fraction of exons that were repressed by RBMX (blue) or independent (grey) that contained RBMX iCLIP tags in surrounding regions (below diagram). *p&lt;0.05 (two-tailed Fisher’s exact test). (<bold>E</bold>) The same analyses as in (<bold>D</bold>) but for exons that were activated by RBMX (red). **p&lt;0.01 (two-tailed Fisher’s exact test). For parts (<bold>D</bold>) and (<bold>E</bold>), the number of RBMX repressed exons was 50, the number of RBMX activated exons was 39, and the number of RBMX-unresponsive exons was 1011.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89705-fig2-figsupp1-v1.tif"/></fig></fig-group><p>In line with previous work on other RNA binding proteins (<xref ref-type="bibr" rid="bib52">Van Nostrand et al., 2020</xref>), only 31% of the RNA splicing events that are controlled by RBMX in both HEK293 cells and MDA-MB-231 cells were identified by iCLIP as direct targets for RBMX binding (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>, and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). Furthermore, when we plotted the fraction of RBMX iCLIP tags present near exons that contain splicing defects in the absence of RBMX, and compared it to iCLIP tags present near a set of exons unaffected by RBMX depletion, we did not detect significant enrichment of RBMX binding within exons that contain splice sites repressed by RBMX (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D, E</xref>). There was significant enrichment of RBMX binding seen in flanking introns (downstream for RBMX-repressed and upstream for RBMX-activated). However, RBMX-responsive internal exons that did contain RBMX iCLIP tags were significantly longer than the ones that are not bound by RBMX (<xref ref-type="fig" rid="fig2">Figure 2D</xref> and <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>). We therefore compared the length of the internal exons regulated (identified by RNA-seq) and bound by RBMX (identified by iCLIP) within protein-coding genes to all internal mRNA exons expressed in HEK293 (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>). We reasoned that larger exons might have a higher chance to be bound by RBMX merely because of their large size. To minimise this effect, we did not take into account the density of RBMX binding and instead considered all exons that contained at least one iCLIP tag. Strikingly, we found that exons regulated and bound by RBMX were significantly longer than the median size of HEK293 mRNA exons which is ~130 bp (<xref ref-type="fig" rid="fig2">Figure 2E</xref>, and <xref ref-type="supplementary-material" rid="fig2sdata2">Figure 2—source data 2</xref>). This led us to test whether RBMX protein is preferentially associated with long exons. For this, we plotted the distribution of internal exons bound and regulated by RBMX together with all internal exons expressed from HEK293 mRNA genes (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>). We found that RBMX controls and binds two different classes of exons: the first has a comparable length to the average HEK293 exon, while the second is extremely long, exceeding 1000 bp in length (<xref ref-type="fig" rid="fig2">Figure 2F</xref>). We defined this second class as ‘ultra-long exons,’ which represented the 17.6% of internal exons regulated by RBMX and 18.9% of the ones that contained RBMX iCLIP tags. These proportions were significantly enriched compared to the general abundance of internal ultra-long exons expressed from HEK293 cells, which was only 0.4% (<xref ref-type="fig" rid="fig2">Figure 2G</xref>). K-mer analyses also showed that while ultra-long exons within mRNAs are rich in AT-rich sequences compared to shorter exons (<xref ref-type="fig" rid="fig2">Figure 2H</xref>), the ultra-long exons that are either regulated or bound by RBMX displayed enrichment of AG-rich sequences (<xref ref-type="fig" rid="fig2">Figure 2I</xref>), consistent with our identified RBMX-recognised sequences (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Overall, this data revealed a function for RBMX in the regulation of splicing of a particular group of ultra-long exons.</p></sec><sec id="s2-3"><title>RBMX is important for proper splicing inclusion of full-length ultra-long exons within genes involved in processes including DNA repair and chromosome biology</title><p>We next wondered whether ultra-long exons regulated by RBMX (which represented 11.6% of all ultra-long internal exons from genes expressed in HEK293) had any particular feature compared to ultra-long exons that were RBMX-independent. To determine whether RBMX regulates particular classes of genes we performed Gene ontology analysis. Both the genes bound by RBMX (detected using iCLIP, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>) and regulated by RBMX in both MDA-MB-231 and HEK293 cell lines (detected using RNA-seq, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>) each showed individual global enrichment in functions connected to genome stability and gene expression. Similarly, Gene ontology analyses for genes that contained ultra-long exons bound by and dependent on RBMX for correct splicing were enriched in pathways involving cell cycle, DNA repair, and chromosome regulation, compared to all expressed genes with ultra-long exons (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). These data are consistent with published observations (<xref ref-type="bibr" rid="bib1">Adamson et al., 2012</xref>; <xref ref-type="bibr" rid="bib39">Munschauer et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Zheng et al., 2020</xref>) that depletion of RBMX reduces genome stability. In addition, comet assays also detected increased levels of genome instability after RBMX depletion (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C, D</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>RBMX protein is important for full-length splicing inclusion of ultra-long exons involved in DNA repair and chromosome biology.</title><p>(<bold>A</bold>) Gene ontology analysis of genes with ultra-long exons regulated and bound by RBMX displaying significant gene ontology biological process (GOBP) terms containing at least 5% of the total gene list. FDR, False Discovery Rate. Count, number of genes in the GOBP group. GeneRatio, proportion of genes in the GOBP group relative to the full list of RBMX-regulated genes. (<bold>B</bold>) Snapshot of RNA-seq merged tracks from MDA-MB-231 cells and RBMX iCLIP tags from HEK293 cells from the IGV genome browser shows cryptic 3ʹ splice sites repressed by RBMX in <italic>ETAA1</italic> exon 5. At the bottom, the schematic of PCR products identified by RT-PCR in (<bold>C</bold>). (<bold>C</bold>) RT-PCR analysis shows splicing inclusion of <italic>ETAA1</italic> exon 5 upon siRNA-mediated depletion of RBMX in the indicated cell lines (separate lanes correspond to analysis of independent biological replicate samples). (<bold>D</bold>) Western blot analysis shows that ETAA1 protein expression is dependent on RBMX. Anti-Tubulin detection was used as loading control (separate lanes correspond to independent biological replicate samples). (<bold>E</bold>) Snapshot of RNA-seq merged tracks from MDA-MB-231 cells and RBMX iCLIP tags from HEK293 cells from the IGV genome browser shows RBMX represses a cryptic 3ʹ splice site within the ultra-long exon 13 of <italic>REV3L</italic>. At the bottom, the schematic of PCR products identified by RT-PCR in (<bold>F</bold>). (<bold>F</bold>) RT-PCR analysis shows splicing inclusion of <italic>REV3L</italic> exon 13 upon siRNA-mediated depletion of RBMX in the indicated cell lines (separate lanes correspond to the analysis of independent biological replicate samples). (<bold>G</bold>) Snapshot of RNA-seq merged tracks from MDA-MB-231 cells and RBMX iCLIP tags from HEK293 cells from IGV genome browser. The location of experimentally mapped branchpoints relative to RBMX binding is indicated.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Gene ontology analyses related to <xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A, B</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89705-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89705-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Further analysis of gene categories encoding mRNAs bound by RBMX and association with genome stability.</title><p>(<bold>A</bold>) Gene ontology analysis of genes bound by RBMX as identified by individual nucleotide resolution crosslinking and immunoprecipitation (iCLIP), displaying the top 20 significant gene ontology biological process (GOBP). Adjusted p-value were produced using the Benjamini-Hochberg method. Count, number of genes in the GOBP group. GeneRatio, proportion of genes in the GOBP group relative to the full list of RBMX-regulated genes. (<bold>B</bold>) Analysis as in (<bold>A</bold>) but relative to genes regulated by RBMX in both MDA-MB-231 (this study) and HEK293 (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>) as identified by RNA-seq. GOBP terms containing at least 5% of the total gene list are shown. FDR, False Discovery Rate. (<bold>C</bold>) Comet assay shows increased formation of DNA breaks in U2-OS cells treated with RBMX siRNA. Direction of the comets is shown. Scale bars 200 µm. (<bold>D</bold>) Quantification of percentage of DNA in the tail of comets. n=58 cells in both conditions. ****p&lt;0.0001 (Mann-Whitney test).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89705-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Further analysis of cryptic splicing patterns within the <italic>ETAA1</italic> and <italic>ATRX</italic> mRNAs.</title><p>(<bold>A</bold>) Snapshot of RNA-seq merged tracks from HEK293 cells. <xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref> from the IGV genome browser shows cryptic 3ʹ splice sites repressed by RBMX in <italic>ETAA1</italic> exon 5. (<bold>B</bold>) Schematic of ETAA1 protein in normal conditions and expected ETAA1 protein in RBMX-depleted cells. (<bold>C</bold>) Snapshot of RNA-seq merged tracks from MDA-MB-231 cells and RBMX individual nucleotide resolution crosslinking and immunoprecipitation (iCLIP) tags from HEK293 cells from the IGV genome browser shows an exitron repressed by RBMX in <italic>ATRX</italic> exon 9. (<bold>D</bold>) Schematic representation of <italic>ETAA1</italic> minigene cloned within pXJ41. (<bold>E</bold>) Example RT-PCR from <italic>ETAA1</italic> minigene shows detection of both the normal and cryptic version of exon 5. (<bold>F</bold>) Schematic of RT-PCR assay to detect branchpoints used during cryptic splicing of <italic>ETAA1</italic> exon 5. (<bold>G</bold>) RT-PCR analysis for mapping branchpoints used during <italic>ETAA1</italic> cryptic splicing (see <xref ref-type="fig" rid="fig3">Figure 3G</xref>). The distance from the relative cryptic splice site and from the RBMX binding site as defined by iCLIP is indicated.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89705-fig3-figsupp2-v1.tif"/></fig></fig-group><p>The above data indicated that RBMX-RNA binding interactions and splicing control by RBMX are particularly associated with long internal exons and enriched within classes of genes involved in genome stability. These exons included the 2.1 Kb exon 5 of the <italic>ETAA1</italic> (<italic>Ewings Tumour Associated Antigen 1</italic>) gene, where RBMX potently represses a cryptic 3ʹ splice site that reduces the size of this exon from 2.1 Kb to 100 bp (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>). RT-PCR analysis confirmed that RBMX depletion causes a much shorter version of <italic>ETAA1</italic> exon 5 to prevail, particularly in MDA-MB-231 and NCI-H520 cells, but less in MCF7 cells (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). <italic>ETAA1</italic> encodes a replication stress protein that accumulates at sites of DNA damage and is a component of the ATR signalling response (<xref ref-type="bibr" rid="bib5">Bass et al., 2016</xref>). Selection of RBMX-repressed cryptic 3ʹ splice sites within <italic>ETAA1</italic> exon 5 removes a long portion of the open reading frame (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>). Consistent with the penetrance of this <italic>ETAA1</italic> splicing defect being sufficiently high to affect protein production, no ETAA1 protein was detectable 72 hr after RBMX depletion from MDA-MB-231 cells (<xref ref-type="fig" rid="fig3">Figure 3D</xref>).</p><p>Another ultra-long exon is found within the <italic>REV3L</italic> gene that encodes the catalytic subunit of DNA polymerase ζ that functions in translesion DNA synthesis (<xref ref-type="bibr" rid="bib37">Martin and Wood, 2019</xref>). RBMX similarly represses a cryptic 3ʹ splice site within the ultra-long exon 13 of the <italic>REV3L</italic> gene (~4.2 Kb), that has an extremely high density of RBMX binding (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). RT-PCR analysis confirmed a strong splicing switch to a cryptic splice site within <italic>REV3L</italic> exon 13 after RBMX was depleted from MDA-MB-231, MCF7, and NCI-H520 cells (<xref ref-type="fig" rid="fig3">Figure 3F</xref>).</p><p>We also detected extremely high-density RBMX protein binding within exon 9 of the <italic>ATRX</italic> gene (3 Kb in length) that encodes a chromatin remodelling protein involved in mitosis. Depletion of RBMX results in the expression of a shortened version of <italic>ATRX</italic> exon 9, caused by the formation of an exitron through the selection of cryptic 5ʹ and 3ʹ splice sites within exon 9 (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2C</xref>).</p></sec><sec id="s2-4"><title>RBMX protein-RNA interactions may insulate important splicing signals from the spliceosome</title><p>The iCLIP data suggested a model where RBMX protein binding may insulate ultra-long exons so that cryptic splice sites cannot be accessed by the spliceosome. This model predicted that RBMX binding sites would be close to important sequences used for the selection of cryptic splice sites. RBMX iCLIP tags mapped just upstream of the cryptic 3ʹ splice sites within <italic>ETAA1</italic> exon 5 in HEK293 cells and MDA-MB-231 cells after RBMX depletion (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), suggesting that RBMX may bind close to the branchpoints used to generate these cryptic splicing patterns. However, although usually located close to their associated 3ʹ splice sites, in some cases branchpoints can be located far upstream (<xref ref-type="bibr" rid="bib20">Gooding et al., 2006</xref>). We tested the prediction that RBMX may sterically interfere with components of the spliceosome by directly mapping the branchpoints associated with the use of these cryptic <italic>ETAA1</italic> splice sites. To facilitate mapping of the branchpoint sequences used by the cryptic 3ʹ splice site within <italic>ETAA1</italic> exon 5, we made a minigene by cloning the ultra-long <italic>ETAA1</italic> exon 5 and flanking intron sequences between constitutively spliced β-globin exons (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2D</xref>). Confirming that this minigene recapitulated cryptic splicing patterns, after transfection into HEK293 cells we could detect splicing inclusion of both the full-length and shorter (cryptic) versions of <italic>ETAA1</italic> exon 5 mRNA isoforms using multiplex RT-PCR (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2E</xref>). We then used an RT-PCR assay (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2F</xref>) to monitor the position of branchpoint just upstream of the cryptic 3ʹ splice sites of <italic>ETAA1</italic> exon 5 (<xref ref-type="bibr" rid="bib31">Královičová et al., 2021</xref>). Sanger sequencing of the amplification product made in this assay confirmed that the branchpoint sequences used by these cryptic 3ʹ splice sites are adjacent to RBMX binding sites (<xref ref-type="fig" rid="fig3">Figure 3G</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2G</xref>).</p></sec><sec id="s2-5"><title>RBMXL2 and RBMY can replace the activity of RBMX in somatic cells</title><p>The above data showed that although RBMX can activate the splicing of some exons, it predominantly operates as a splicing repressor in human somatic cells, and moreover has a key role in repressing cryptic splicing within ultra-long exons. This pattern of RBMX activity is thus very similar to that previously reported for RBMXL2 in the germline, where RBMXL2 represses cryptic splice sites during meiosis. RBMXL2 is expressed during male meiosis when the X chromosome is silenced. To directly mimic this switch in protein expression we constructed a HEK293 RBMXL2-FLAG tetracycline-inducible cell line, from which we depleted RBMX using siRNA (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Western blots showed that RBMX was successfully depleted after siRNA treatment, and the RBMXL2-FLAG protein was strongly expressed after tetracycline induction, thus simulating their relative expression patterns in meiotic cells (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). We globally investigated patterns of splicing in these rescue experiments by performing RNA-seq analysis of each of the experimental groups. Strikingly, almost 80% of splicing defects that we could detect after RBMX-depletion were rescued by tetracycline-induced RBMXL2 (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, and <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>). Exons rescued by RBMXL2 tended to be larger than exons not restored (<xref ref-type="fig" rid="fig4">Figure 4D</xref>), and most of the splice events that were restored by RBMXL2 expression had nearby RBMX binding sites evidenced by iCLIP (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). We then validated three cryptic splicing patterns by RT-PCR. Confirming our previous finding, in the absence of tetracycline treatment depletion of RBMX led to an increased selection of cryptic splice sites within <italic>ETAA1</italic> exon 5 and <italic>REV3L</italic> exon 13, and to the formation of an exitron within <italic>ATRX</italic> exon 9 (<xref ref-type="fig" rid="fig4">Figure 4F–K</xref>, compare lanes 1–3 with lanes 4–6). Consistent with our RNA-seq analysis (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A–C</xref>), tetracycline-induction of RBMXL2 was sufficient to repress production of each of these aberrant splice isoforms (<xref ref-type="fig" rid="fig4">Figure 4F–K</xref>, compare lanes 7–9 with lanes 10–12). These experiments indicate that RBMXL2 is able to replace RBMX activity in regulating ultra-long exons within somatic cells.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>RBMXL2 can replace the activity of RBMX in ensuring proper splicing inclusion of ultra-long exons.</title><p>(<bold>A</bold>) Schematic of the time-course experiment used to analyse human RBMXL2 function in RBMX-depleted HEK293 cells. All conditions were repeated in biological triplicates. (<bold>B</bold>) Western blot analysis shows that RBMXL2-FLAG protein is stably expressed in HEK293 cells after 24 hr of tetracycline induction, and RBMX protein is successfully depleted after 72 hr of siRNA treatment. Separate lanes correspond to independent biological replicate samples. (<bold>C</bold>) Pie chart showing the percentage of splicing events detected by RNA-seq that were defective in RBMX-depleted cells and restored by overexpression of RBMXL2. (<bold>D</bold>) Boxplot analysis shows the distribution of exon sizes relative to exons undergoing defective splicing in RBMX-depleted cells, grouped by whether splicing patters were restored by RBMXL2 overexpression. **p&lt;0.01 (Mann-Whitney test). (<bold>E</bold>) Bar plot analysis shows the proportion of exons containing RBMX individual nucleotide resolution crosslinking and immunoprecipitation (iCLIP) tags, grouped by whether splicing patterns were restored by RBMXL2 overexpression. ****p&lt;0.0001 (Chi-squared test). (<bold>F, H, J</bold>) Capillary gel electrophoretograms show RNA processing patterns of endogenous ultra-long exons within <italic>ETAA1</italic>, <italic>REV3L,</italic> and <italic>ATRX</italic> controlled by RBMX and RBMXL2 analysed using isoform-specific RT-PCR. Separate lanes correspond to the analysis of independent biological replicate samples. (<bold>G, I, K</bold>) Bar charts showing percentage splicing inclusion (PSI) of cryptic isoforms from the endogenous <italic>ETAA1</italic>, <italic>REV3L,</italic> and <italic>ATRX</italic> genes under the different experimental conditions, measured in experiments in (<bold>F</bold>), (<bold>H</bold>) and (<bold>J</bold>), respectively. p-values were calculated using an unpaired t-test. * p&lt; 0.05; ***p&lt; 0.001; ****p&lt;0.0001, using n=3 biological replicates for each condition as shown in capillary gel electrophoretograms.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>List of splicing defects restored by overexpression of RBMXL2 related to <xref ref-type="fig" rid="fig4">Figure 4C</xref>.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-89705-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89705-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>RBMXL2 can replace the activity of RBMX in ensuring proper splicing inclusion of ultra-long exons.</title><p>(<bold>A–C</bold>) Snapshot of RNA-seq merged tracks from HEK293 cells from the IGV genome browser shows tetracycline-induced expression of RBMXL2 restores correct splicing patterns within <italic>ETAA1</italic> exon 5 (<bold>A</bold>), <italic>REV3L</italic> exon 13 (<bold>B</bold>), and <italic>ATRX</italic> exon 9 (<bold>C</bold>). Location of the splicing defects in RBMX-depleted cells is shown with red dotted lines.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89705-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>RBMY can replace the activity of RBMX in ensuring proper splicing inclusion of ultra-long exons.</title><p>(<bold>A</bold>) Western blot analysis shows that human RBMY-FLAG protein is stably expressed in HEK293 cells after 24 hr of tetracycline induction, and RBMX protein is successfully depleted after 72 hr of siRNA treatment. All conditions were repeated in biological triplicate. (<bold>B, D, F</bold>) Capillary gel electrophoretograms show RNA processing patterns of endogenous ultra-long exons within <italic>ETAA1</italic>, <italic>REV3L,</italic> and <italic>ATRX</italic> controlled by RBMX and RBMY analysed using isoform-specific RT-PCR. Separate lanes correspond to the analysis of independent biological replicate samples. (<bold>C, E, G</bold>) Bar charts showing percentage splicing inclusion (PSI) of cryptic isoforms from the endogenous <italic>ETAA1</italic>, <italic>REV3L,</italic> and <italic>ATRX</italic> genes under the different experimental conditions, measured in experiments in (<bold>B</bold>), (<bold>D</bold>), and (<bold>F</bold>) respectively. p-values were calculated using an unpaired t-test. ***p&lt;0.001; ****p&lt;0.0001, for n=3 biological replicates as shown in capillary gel electrophoretograms.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89705-fig4-figsupp2-v1.tif"/></fig></fig-group><p>RBMX and RBMXL2 are both more distantly related to the Y chromosome-encoded RBMY protein, with RBMX and RBMY diverging when the mammalian Y chromosome evolved (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). RBMY has also been implicated in splicing control (<xref ref-type="bibr" rid="bib40">Nasim et al., 2003</xref>; <xref ref-type="bibr" rid="bib55">Venables et al., 2000</xref>), but its functions are very poorly understood. We thus tested whether RBMY might also be performing a similar function to RBMX. Employing a HEK293 cell line containing tetracycline-inducible, FLAG-tagged RBMY protein, we detected successful recovery of normal splicing patterns of the ultra-long exons within the <italic>ETAA1</italic>, <italic>REV3L,</italic> and <italic>ATRX</italic> genes within RBMX-depleted cells 24 hr after tetracycline induction of RBMY (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). These results indicate that even despite its more extensive divergence, RBMY can also functionally replace RBMX in cryptic splice site control within long exons. Thus, splicing control mechanisms by RBMX family proteins pre-date the evolution of the mammalian X and Y chromosomes.</p></sec><sec id="s2-6"><title>The disordered domain of RBMXL2 is required for efficient splicing control of ultra-long exons</title><p>The above data showed that RBMX predominantly operates as a splicing repressor in somatic cells, thus performing a functionally parallel role to RBMXL2 in the germline. Although RBMX contains an RRM domain that is the most highly conserved region compared with RBMXL2 and RBMY, splicing activation by RBMX depends on its C-terminal disordered domain that also binds to RNA (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib38">Moursy et al., 2014</xref>). We thus reasoned that if RBMX and RBMXL2 were performing equivalent molecular functions, the rescue of splicing by RBMXL2 should be mediated by the disordered region of RBMXL2 alone, independent of the RRM (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>; <xref ref-type="bibr" rid="bib38">Moursy et al., 2014</xref>). To test this prediction, we created a new tetracycline-inducible HEK293 cell line expressing the disordered region of the RBMXL2 protein and not the RRM domain (RBMXL2ΔRRM, <xref ref-type="fig" rid="fig5">Figure 5A</xref>). Tetracycline induction of this RBMXL2ΔRRM protein was able to rescue siRNA-mediated depletion of RBMX (<xref ref-type="fig" rid="fig5">Figure 5B–G</xref>), directly confirming that the C-terminal disordered domain of RBMXL2 protein is responsible for mediating cryptic splicing repression.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The disordered domain of RBMXL2 is required to mediate splicing control of ultra-long exons in HEK293 cells.</title><p>(<bold>A</bold>) Western blot analysis shows that RBMXL2ΔRRM-FLAG protein is stably expressed in HEK293 cells after 24 hr of tetracycline induction, and RBMX protein is successfully depleted after 72 hr of siRNA treatment. Separate lanes correspond to the analysis of independent biological replicate samples. (<bold>B, D, F</bold>) Capillary gel electrophoretograms show RNA processing patterns of endogenous ultra-long exons within <italic>ETAA1</italic>, <italic>REV3L,</italic> and <italic>ATRX</italic> analysed using isoform-specific RT-PCR. Separate lanes correspond to the analysis of independent biological replicate samples. (<bold>C, E, G</bold>) Bar charts showing percentage splicing inclusion (PSI) of cryptic isoforms from the endogenous <italic>ETAA1</italic>, <italic>REV3L,</italic> and <italic>ATRX</italic> genes under the different experimental conditions, measured in experiments in (<bold>B</bold>), (<bold>D</bold>), and (<bold>F</bold>), respectively. p-values were calculated using an unpaired t-test. ****p&lt;0.0001, using biologically independent sampleas.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89705-fig5-v1.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We previously showed that the germ cell-specific RBMXL2 protein represses cryptic splice site selection during meiotic prophase. Here, we find that this is part of a bigger picture, where the closely related but more ubiquitously expressed RBMX protein also provides a similar activity within somatic cells. Supporting this conclusion, both RBMX and RBMXL2 proteins most frequently operate as splicing repressors in their respective cell types. We further find that RBMX binds and is key for proper splicing inclusion of a group of ultra-long exons, defined as exceeding 1 Kb in length. RBMXL2 similarly represses cryptic splice sites within ultra-long exons of genes involved in genome stability including <italic>Brca2</italic> and <italic>Meioc</italic> (<xref ref-type="bibr" rid="bib15">Ehrmann et al., 2019</xref>). Furthermore, RBMXL2 and even the more diverged RBMY protein are able to provide a direct replacement for RBMX splicing control within human somatic cells. Although many of the splice sites within ultra-long exons we find to be repressed by RBMX are already annotated, they are not usually selected in the human cell lines we investigated and thus represent potential decoy splice sites that would interfere with full-length gene expression.</p><p>Long human exons provide an enigma in understanding gene expression. Most human exons have evolved to be quite short (~130 bp) to facilitate a process called exon definition, in which protein-protein interactions between early spliceosome components bound to closely juxtaposed splice sites promote full spliceosome assembly (<xref ref-type="bibr" rid="bib6">Black, 1995</xref>; <xref ref-type="bibr" rid="bib42">Robberson et al., 1990</xref>). Exon definition also requires additional RNA binding proteins to recognise exons and flanking intron sequences. These include members of the SR protein family that bind to exonic splicing enhancers (ESEs) and activate exon inclusion, with exons typically having higher ESE content relative to introns. While the mechanisms that ensure proper splicing inclusion of long exons are not well understood, cryptic splice sites would be statistically more likely to occur within long exons compared to short exons, where they could prevent full-length exon inclusion. Cryptic splice sites within long exons could be particularly problematic (compared to an intronic location) since they would be embedded within a high ESE sequence environment. For example, some long exons require interactions with the SR protein SRSF3 and hnRNP K and phase separation of transcription factors to be spliced (<xref ref-type="bibr" rid="bib28">Kawachi et al., 2021</xref>). Hence, although the functions of hnRNPs in repressing cryptic splice events have often concentrated on their role within introns, other hnRNPs as well as RBMX might also show enriched binding within ultra-long exons to help repress cryptic splice site selection.</p><p>The X chromosome is required for viability. This means that meiotic sex chromosome inactivation (inactivation of the X and Y chromosomes during meiosis) coordinately represses a panel of essential genes on the X chromosome, thus opening the need for alternative routes to fulfil their function (<xref ref-type="bibr" rid="bib50">Turner, 2015</xref>). A number of essential X-linked genes have generated autosomal retrogenes that are expressed during meiosis, although genetic inactivation of some of these retrogenes causes a phenotype that manifests outside of meiosis (<xref ref-type="bibr" rid="bib56">Wang, 2004</xref>). An exception is exemplified by the RPL10 and RPL10L proteins that are 95% identical: <italic>RPL10</italic> mutation causes meiotic arrest, and RPL10L has been shown to directly replace its X-linked ortholog <italic>RPL10</italic> during meiosis (<xref ref-type="bibr" rid="bib26">Jiang et al., 2017</xref>; <xref ref-type="bibr" rid="bib56">Wang, 2004</xref>). <italic>RBMXL2</italic> is the only other X-linked retrogene that has been shown to be essential for meiotic prophase (<xref ref-type="bibr" rid="bib15">Ehrmann et al., 2019</xref>). Here, we show that ectopic expression of RBMXL2 can compensate for the lack of RBMX in somatic cells. This is consistent with a recent model suggesting that RBMXL2 directly replaces RBMX function during meiosis because of transcriptional inactivation of the X chromosome (<xref ref-type="bibr" rid="bib2">Aldalaqan et al., 2022</xref>). This general requirement for functionally similar RBMX family proteins across somatic and germ cells further suggests that RBMX-family functions in splicing control have been required for ~200 million years, since before the divergence of separate <italic>RBMX</italic> and <italic>RBMY</italic> genes early in mammalian evolution.</p><p>The iCLIP data reported here show a high density of RBMX binding within ultra-long exons, consistent with a model in which RBMX protein binds to RNA mask sequences required for cryptic splice site selection. Such RBMX binding would block access to spliceosome components or splicing activator proteins (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Our data show that the C-terminal disordered domain of RBMXL2 protein is sufficient to control splicing inclusion of ultra-long exons. This is exactly analogous to the mechanism of control of splicing activation by RBMX, which occurs via recognition of m6A-modified RNA targets via the C-terminal disordered domain (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>). Intriguingly, global studies have shown that m6A residues are enriched within some long internal exons (<xref ref-type="bibr" rid="bib11">Dominissini et al., 2012</xref>), where they might help facilitate RBMX protein-RNA interactions. The C-terminal disordered region of RBMX is also reported to mediate protein-protein interactions, therefore, shorter exons that show defective splicing in RBMX-depleted cells but are not directly bound by RBMX could rely on different regulatory mechanisms. RBMY, RBMX and RBMXL2 directly interact with the SR protein Tra2β (<xref ref-type="bibr" rid="bib17">Elliott et al., 2000</xref>; <xref ref-type="bibr" rid="bib55">Venables et al., 2000</xref>) and have opposing functions during RNA binding and splicing regulation (<xref ref-type="bibr" rid="bib40">Nasim et al., 2003</xref>; <xref ref-type="bibr" rid="bib55">Venables et al., 2000</xref>). Hence, it is still possible that RBMX family proteins counteract recognition by SR proteins of ESEs near cryptic splice sites via a protein-protein interaction mechanism.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Model of cryptic splice site repression within ultra-long exons by RBMX family proteins.</title><p>Ultra-long exons may be intrinsically fragile as they could contain cryptic splice sites within an environment rich in exonic splicing enhancers (ESEs). RBMX protein binding within ultra-long exons may directly block access of spliceosome components to cryptic splice sites, and depletion of RBMX from somatic cells activates the selection of cryptic splice sites. This means a shorter version of the originally ultra-long exon is included, that fits more easily with exon definition rules normally followed for median-size exons. During meiosis, the lack of RBMX caused by X chromosome inactivation is compensated by the expression of RBMXL2 protein.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-89705-fig6-v1.tif"/></fig><p>Extensive literature shows that RBMX is important for genome stability, including being involved in replication fork activity (<xref ref-type="bibr" rid="bib39">Munschauer et al., 2018</xref>; <xref ref-type="bibr" rid="bib61">Zheng et al., 2020</xref>), sensitivity to genotoxic drugs (<xref ref-type="bibr" rid="bib1">Adamson et al., 2012</xref>) and cell proliferation (<ext-link ext-link-type="uri" xlink:href="https://orcs.thebiogrid.org/Gene/27316">https://orcs.thebiogrid.org/Gene/27316</ext-link>). Interestingly, many of the ultra-long exons controlled by RBMX are within genes important for genome stability, including <italic>REV3L</italic>, <italic>ATRX,</italic> and <italic>ETAA1</italic>. This makes it likely that RBMX contributes to maintaining genome stability by ensuring full-length protein expression of genes important in this process. As an example, we show here that depletion of RBMX protein causes aberrant selection of a high amplitude cryptic splice site within <italic>ETAA1</italic> exon 5 which prevents detectable expression of ETAA1 protein, and contributes to genome instability (<xref ref-type="bibr" rid="bib5">Bass et al., 2016</xref>). Cancer and neurological disorders are amongst the most common human diseases associated with defective DNA damage response (<xref ref-type="bibr" rid="bib25">Jackson and Bartek, 2009</xref>). The double role of RBMX in genome maintenance via both direct participation in the DNA damage response and splicing regulation of genome stability genes could explain why mutations of <italic>RBMX</italic> are associated with an intellectual disability syndrome (<xref ref-type="bibr" rid="bib8">Cai et al., 2021</xref>; <xref ref-type="bibr" rid="bib44">Shashi et al., 2015</xref>), and why RBMX has been identified as a potential tumour suppressor (<xref ref-type="bibr" rid="bib1">Adamson et al., 2012</xref>; <xref ref-type="bibr" rid="bib18">Elliott et al., 2019</xref>). The data reported in this paper thus have implications for understanding the links between RNA processing of unusual exons, genome stability, and intellectual disability.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom"><italic>RBMX</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">NCBI Gene: 27316 Ensembl: ENSG00000147274</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom"><italic>RBMXL2</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">NCBI Gene: 27288 Ensembl: ENSG00000170748</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom"><italic>RBMY/ RBMY1A1</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">NCBI Gene: 5940 Ensembl: ENSG00000234414</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom"><italic>ETAA1</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">NCBI Gene: 54465 Ensembl: ENSG00000143971</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom"><italic>REV3L</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">NCBI Gene: 5980 Ensembl: ENSG00000009413</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Gene (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom"><italic>ATRX</italic></td><td align="left" valign="bottom">GenBank</td><td align="left" valign="bottom">NCBI Gene: 546 Ensembl: ENSG00000085224</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">MDA-MB-231</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">HTB-26</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">MCF7</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">HTB-22</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">U-2 OS</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">HTB-96</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">NCI-H520</td><td align="left" valign="bottom">ATCC</td><td align="left" valign="bottom">HTB-182</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Flp-In–293<break/>Flp-In. T-REx.-293 Cell Line</td><td align="left" valign="bottom">Thermofisher</td><td align="left" valign="bottom">R78007</td><td align="left" valign="bottom">Used to make stable over-expressing cells.</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Flp-In–293 <italic>FLAG-RBMX</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Used to express tagged RBMX protein in human cells. Available from Elliott lab.</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Flp-In–293 <italic>FLAG-RBMXL2</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Used to express tagged RBMXL2 protein in human cells. Available from Elliott lab.</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Flp-In–293 <italic>FLAG-RBMY</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Used to express tagged RBMY protein in human cells. Available from Elliott lab.</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Flp-In–293 <italic>FLAG- RBMXL2ΔRRM</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Used to express tagged RBMX protein without the RRM in human cells. Available from Elliott lab.</td></tr><tr><td align="left" valign="bottom">Chemical compound</td><td align="left" valign="bottom">Tetracycline</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">T7660</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pOG44 (plasmid)</td><td align="left" valign="bottom">Thermofisher<break/>Scientific</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Expresses Flp recombinase.</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">FLAG-pcDNA5 (plasmid)</td><td align="left" valign="bottom">Thermofisher<break/>Scientific</td><td align="left" valign="bottom"/><td align="left" valign="bottom">Expression of constructs in the stable Cell lines was induced by treatment with 1 µg/ml tetracycline for 24 hr.</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pXJ41 (miniGene plasmid)</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib7">Bourgeois et al., 1999</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">siRNAs</td><td align="left" valign="bottom">IDT</td><td align="left" valign="bottom">hs.Ri.RBMX.13.1, hs.Ri.RBMX.13.2</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">anti-FLAG mouse monoclonal antibody</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# F1804<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_262044">AB_262044</ext-link></td><td align="left" valign="bottom">CLIP (5 μg), WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Normal mouse IgG (mouse antibody)</td><td align="left" valign="bottom">Santa Cruz Biotechnology</td><td align="left" valign="bottom">Cat# sc-2025<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_737182">AB_737182</ext-link></td><td align="left" valign="bottom">CLIP: 5 μg</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-RBMX (rabbit polyclonal antibody)</td><td align="left" valign="bottom">Cell Signalling Technology</td><td align="left" valign="bottom">Cat# D7C2V<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2798614">AB_2798614</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-ETAA1 (rabbit polyclonal antibody)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# HPA035048<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10670300">AB_10670300</ext-link></td><td align="left" valign="bottom">WB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-alpha tubulin (rabbit polyclonal antibody)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab18251<break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2210057">AB_2210057</ext-link></td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-GAPDH (mouse monoclonal antibody)</td><td align="left" valign="bottom">Abcepta</td><td align="left" valign="bottom">Cat# P04406</td><td align="left" valign="bottom">WB (1:2000)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">RNeasy Plus Mini Kit</td><td align="left" valign="bottom">Qiagen</td><td align="left" valign="bottom">Cat#74134</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Comet Assay Kit</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">ab238544</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fastqc</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://anaconda.org/">https://anaconda.org/</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"> See: <xref ref-type="bibr" rid="bib3">Andrews, 2010</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">STAR</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://anaconda.org/">https://anaconda.org/</ext-link></td><td align="left" valign="bottom">v.2.4.2</td><td align="left" valign="bottom">See: <xref ref-type="bibr" rid="bib10">Dobin et al., 2013</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Salmon</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://anaconda.org/">https://anaconda.org/</ext-link></td><td align="left" valign="bottom">v.0.9.1</td><td align="left" valign="bottom">See: <xref ref-type="bibr" rid="bib41">Patro et al., 2017</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Hisat2</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://anaconda.org/">https://anaconda.org/</ext-link></td><td align="left" valign="bottom">v.2.2.1</td><td align="left" valign="bottom">See: <xref ref-type="bibr" rid="bib29">Kim et al., 2015</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Samtools</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://anaconda.org/">https://anaconda.org/</ext-link></td><td align="left" valign="bottom">v.1.14</td><td align="left" valign="bottom">See: <xref ref-type="bibr" rid="bib32">Li et al., 2009</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MAJIQ</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://anaconda.org/">https://anaconda.org/</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">See <xref ref-type="bibr" rid="bib53">Vaquero-Garcia et al., 2016</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">SUPPA2</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://anaconda.org/">https://anaconda.org/</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">See: <xref ref-type="bibr" rid="bib49">Trincado et al., 2018</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">iCLIPlib</td><td align="left" valign="bottom">Github, <break/><ext-link ext-link-type="uri" xlink:href="https://github.com/sudlab/iCLIPlib">https://github.com/sudlab/iCLIPlib</ext-link>,<break/>copy archived at <xref ref-type="bibr" rid="bib47">Sudbery et al., 2022</xref>.</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">iMAPS</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://imaps.goodwright.com/">https://imaps.goodwright.com/</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">R/RStudio</td><td align="left" valign="bottom">Cran</td><td align="left" valign="bottom">v.3.5.1</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">DESeq2</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/">https://bioconductor.org/</ext-link></td><td align="left" valign="bottom">v.1.16.1</td><td align="left" valign="bottom">See: <xref ref-type="bibr" rid="bib34">Love et al., 2014</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">biomaRt</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/">https://bioconductor.org/</ext-link></td><td align="left" valign="bottom">v.2.52.0</td><td align="left" valign="bottom">See: <xref ref-type="bibr" rid="bib12">Durinck et al., 2005</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">clusterProfiler::enrichGO</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/">https://bioconductor.org/</ext-link></td><td align="left" valign="bottom">v.4.4.4</td><td align="left" valign="bottom">See: <xref ref-type="bibr" rid="bib58">Yu et al., 2012</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Revigo</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/">https://bioconductor.org/</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">See: <xref ref-type="bibr" rid="bib48">Supek et al., 2011</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ggplot2</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/">https://bioconductor.org/</ext-link></td><td align="left" valign="bottom">v.3.3.6</td><td align="left" valign="bottom">See: <xref ref-type="bibr" rid="bib57">Wickham, 2016</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ChIPseeker</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/">https://bioconductor.org/</ext-link></td><td align="left" valign="bottom">v.1.32.0</td><td align="left" valign="bottom">See: <xref ref-type="bibr" rid="bib59">Yu et al., 2015</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Pseudorank</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/">https://bioconductor.org/</ext-link></td><td align="left" valign="bottom">v.1.0.1</td><td align="left" valign="bottom">See: <xref ref-type="bibr" rid="bib23">Happ et al., 2020</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Integrative Genomics Viewer</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://igv.org/">https://igv.org/</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">See: <xref ref-type="bibr" rid="bib43">Robinson et al., 2011</xref></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">GraphPad Prism</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com">https://www.graphpad.com</ext-link></td><td align="left" valign="bottom">v.9.5.0</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MedCalc</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://medcalc.org/">https://medcalc.org/</ext-link></td><td align="char" char="." valign="bottom">20.218</td><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Cell culture and cell lines</title><p>MDA-MB-231 (ATCC HTB-26), MCF7 (ATCC HTB-22), U-2 OS (ATCC HTB-96), and NCI-H520 (ATCC HTB-182) cells were maintained in Dulbecco′s Modified Eagle′s Medium (DMEM) high glucose pyruvate medium (Gibco, #10569010), supplemented with 10% fetal bovine serum (FBS, Gibco, #21875034), and 1% Penicillin-Streptomycin (Gibco, #15140130). HEK293 (ATCC CRL-1573) were maintained in DMEM plus 10% fetal bovine serum. Cell line validation was carried out using STR profiling according to the ATCC guidelines. All cell lines underwent regular mycoplasma testing.</p></sec><sec id="s4-2"><title>Generation of tetracycline-inducible cell lines</title><p><italic>RMBX</italic>, <italic>RBMXL2</italic>, <italic>RBMY,</italic> and <italic>RBMXL2ΔRRM</italic> genes were cloned onto a FLAG-pcDNA5 vector and co-transfected with pOG44 plasmid into Flp-In T-REX HEK293 cells as previously described (<xref ref-type="bibr" rid="bib14">Ehrmann et al., 2016</xref>). RBMX-FLAG, RBMXL2-FLAG, RBMY-FLAG, and RBMXL2ΔRRM-FLAG expression was induced by the addition of 1 µg/ml tetracycline (Sigma-Aldrich) to promote expression via a tetracycline-inducible promoter. The Flp-In HEK293 cells were cultured in high glucose pyruvate medium (Gibco, #10569010), supplemented with 10% FBS (Gibco, #21875034), and 1% Penicillin-Streptomycin (Gibco, #15140130).</p></sec><sec id="s4-3"><title>siRNA knockdown and tetracycline induction</title><p>RBMX transient knockdown was established using two different pre-designed siRNAs targeting <italic>RBMX</italic> mRNA transcripts (hs.Ri.RBMX.13.1 and hs.Ri.RBMX.13.2, from Integrated DNA Technologies). Negative control cells were transfected with control siRNA (Integrated DNA Technologies, # 51-01-14-04). Cells were seeded onto six-well plates forward transfected with Lipofectamine RNAiMAX transfection reagent (Invitrogen, # 13778150) according to manufacturer′s instructions using 30 pmol of siRNA for 72 hr at 37 °C before harvesting. For tetracycline-inducible cell lines, Flp-In HEK293 cells expressing either RBMXL2-FLAG, or RBMY-FLAG, or RBMXL2ΔRRM-FLAG genes were similarly seeded onto six-well plates and treated with RBMX and control siRNAs for 72 hr at 37 °C. 24 hr before harvesting 1 µg/ml of tetracycline (Sigma-Aldrich) was added to half of the siRNA-treated samples to promote the expression of FLAG-tagged proteins.</p></sec><sec id="s4-4"><title>RNA-seq</title><p>RNA was extracted from cells using RNeasy Plus Mini Kit (Qiagen #74134) following the manufacturer’s instructions and re-suspended in nuclease-free water. RNA samples were DNase treated (Invitrogen, AM1906). For siRNA-treated MDA-MB-231 cells, paired-end sequencing was done initially for two samples, one of negative control and one of RBMX knock-down, using an Illumina NextSeq 500 instrument. Adapters were trimmed using trimmomatic v.0.32. Three additional biological repeats of negative control and RBMX siRNA-treated MDA-MB-231 cells were then sequenced using an Illumina HiSeq 2000 instrument. The base quality of raw sequencing reads was checked with FastQC (<xref ref-type="bibr" rid="bib3">Andrews, 2010</xref>). RNA-seq reads were mapped to the human genome assembly GRCh38/hg38 using STAR v.2.4.2 (<xref ref-type="bibr" rid="bib10">Dobin et al., 2013</xref>) and subsequently quantified with Salmon v.0.9.1 (<xref ref-type="bibr" rid="bib41">Patro et al., 2017</xref>) and DESeq2 v.1.16.1 (<xref ref-type="bibr" rid="bib34">Love et al., 2014</xref>) on R v.3.5.1. All snapshots indicate merged tracks produced using samtools (<xref ref-type="bibr" rid="bib32">Li et al., 2009</xref>) and visualised with IGV (<xref ref-type="bibr" rid="bib43">Robinson et al., 2011</xref>). For HEK293 cells treated with either RBMX or control siRNA, either in the absence or in the presence of tetracycline, RNAs were sequenced using an Illumina NextSeq 500 instrument. Quality of the reads was checked with FastQC (<xref ref-type="bibr" rid="bib3">Andrews, 2010</xref>). Reads were then aligned to the human genome assembly GRCh38/hg38 to produce BAM files using hisat2 v.2.2.1 (<xref ref-type="bibr" rid="bib29">Kim et al., 2015</xref>) and samtools v.1.14 (<xref ref-type="bibr" rid="bib32">Li et al., 2009</xref>) and visualised using IGV (<xref ref-type="bibr" rid="bib43">Robinson et al., 2011</xref>).</p></sec><sec id="s4-5"><title>Identification of splicing changes</title><p>Initial comparison of single individual RNA-seq samples from RBMX-depleted and control cells was carried out using MAJIQ (<xref ref-type="bibr" rid="bib53">Vaquero-Garcia et al., 2016</xref>), which identified 596 unique local splicing variations (LSV) at a 20% dPSI minimum cut off from 505 different genes potentially regulated by RBMX. These LSVs were then manually inspected using the RNA-seq data from the second RNA sequencing of biological replicates for both RBMX-depleted and control cells, by visual analysis on the UCSC browser (<xref ref-type="bibr" rid="bib27">Karolchik et al., 2014</xref>) to identify consistent splicing changes that depend on RBMX expression. The triplicate RNA-seq samples were further analysed for splicing variations using SUPPA2 (<xref ref-type="bibr" rid="bib49">Trincado et al., 2018</xref>), which identified 6702 differential splicing isoforms with p&lt;0.05. Predicted splicing changes were confirmed by visual inspection of RNA-seq reads using the UCSC (<xref ref-type="bibr" rid="bib27">Karolchik et al., 2014</xref>) and IGV (<xref ref-type="bibr" rid="bib43">Robinson et al., 2011</xref>) genome browsers. Identification of common splicing changes between RBMX-depleted MDA-MB-231 and HEK293 cells was done by comparing data from this study with data from GSE74085 (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>). For comparative analysis, a negative set of cassette exons that were non-responsive to RBMX depletion were those where every splice junction had an absolute dPSI of 2% or less in two of the knockdown experiments analysed.</p></sec><sec id="s4-6"><title>iCLIP</title><p>iCLIP experiments were performed on triplicate samples in RBMX-FLAG expressing Flp-In HEK293 cells using the protocol described in <xref ref-type="bibr" rid="bib24">Huppertz et al., 2014</xref>. Briefly, cells were grown in 10 cm tissue culture dishes and irradiated with 400 mJ cm−2 ultraviolet-C light on ice, lysed, and sonicated using Diagenode Bioruptor Pico sonicator for 10 cycles with alternating 30 s on/off at low intensity and 1 mg of protein was digested with 4 U of Turbo DNase (Ambion, AM2238) and 0.28 U/ml (low) or 2.5 U/ml (high) of RNAse I (Thermo Scientific, EN0602). The digested lysates were immunoprecipitated with Protein G Dynabeads (Invitrogen, #10003D) and either 5 μg anti-FLAG antibody (Sigma-Aldrich, F1804) or 5 μg IgG (Santa Cruz biotechnology, sc-2025). Subsequently, a pre-adenylated adaptor L3-IR-App (<xref ref-type="bibr" rid="bib60">Zarnegar et al., 2016</xref>) was ligated to the 3ʹ of the RNA fragments. The captured Protein-RNA complexes were visualised using Odyssey LI-COR CLx imager scanning in both the 700 nm and 800 nm channels. The RNA bound to the proteins was purified, and reverse transcribed with barcoded RT oligos complementary to the L3 adaptor. The cDNAs were purified using Agencourt AMPure XP beads (Beckman Coulter, A63880), circularised, and linearised by PCR amplification. The libraries were gel purified and sequenced on Illumina NextSeq 500. All iCLIP sequencing read analysis was performed on the iMaps webserver (<ext-link ext-link-type="uri" xlink:href="http://imaps.genialis.com/">imaps.goodwright.com</ext-link>) using standardised icount demultiplex and analyse work flow. Briefly, reads were demultiplexed using the experimental barcodes, UMIs (unique molecular identifiers) were used to remove PCR duplicates, and reads were mapped to the human genome sequence (version hg38/GRCh37) using STAR (<xref ref-type="bibr" rid="bib10">Dobin et al., 2013</xref>). Crosslinked sites were identified on the iMAPS platform and the iCount group analysis workflow was used to merge the replicate samples. For enrichment analysis of RBMX iCLIP around cassette exons we compared the number of exons that contained iCLIP binding events that were regulated by RBMX (either repressed or activated) versus non-responsive RBMX cassette exons sets (defined above) in each of the following regions: the proximal intronic region within 300 nt upstream of the 3ʹ splice site, the proximal intronic region within 300 nt downstream of the 5ʹ splice site, and the splice site proximal exonic regions within 50 nt of the 3ʹ splice site or the 5ʹ splice site.</p></sec><sec id="s4-7"><title>K-mer enrichment analysis</title><p>K-mer motif enrichment was performed with the z-score approach using the kmer_enrichment.py script from the iCLIPlib suite of tools (<ext-link ext-link-type="uri" xlink:href="https://github.com/sudlab/iCLIPlib">https://github.com/sudlab/iCLIPlib</ext-link>, copy archived at <xref ref-type="bibr" rid="bib47">Sudbery et al., 2022</xref>). All transcripts for each non-overlapping protein-coding gene from the Ensembl v.105 annotations were merged into a single transcript, used for this analysis, using cgat gtf2gtf <monospace>--method=merge-transcripts</monospace> (<xref ref-type="bibr" rid="bib46">Sims et al., 2014</xref>). Each crosslinked base from the merged replicate bam file was extended 15 nucleotides in each direction. For every hexamer, the number of times a crosslink site overlaps a hexamer start position was counted within the gene and then summed across all genes. This occurrence was also calculated across 100 randomisations of the crosslink positions within genes. The z-score was thus calculated for each hexamer as (occurrence – occurrence in randomised sequences)/standard deviation of occurrence in randomised sequences. For motif enrichment analysis within ultra-long internal exons, we compared hexamer occurrence within the set of internal exons from Ensembl v.105 mRNA canonical transcripts of 1000 nt or more and compared those to internal exons of less than 1000 nt and calculated a z-score for each hexamer. A similar analysis was done by stratifying the set of ultra-long internal exons to those with RBMX binding or splicing regulation compared to those with no evidence of RBMX activity.</p></sec><sec id="s4-8"><title>Exon size analysis</title><p>Analyses of exon sizes from RNA-seq data (<xref ref-type="fig" rid="fig2">Figures 2D</xref> and <xref ref-type="fig" rid="fig4">4D</xref>) were used using GraphPad Prism 9.5.0. Annotations of all human exons related to position and size were downloaded from Ensembl Genes v.105 (<ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/biomart/">http://www.ensembl.org/biomart/</ext-link>). Selection of exons expressed in HEK293 was performed using data from control RNA-seq samples of the dataset GSE74085 (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>), subsequently filtered to focus on mRNA exons using biomaRt v.2.52.0 (<xref ref-type="bibr" rid="bib12">Durinck et al., 2005</xref>). Size of the internal mRNA exons containing RBMX-regulated splicing patterns was annotated using IGV (<xref ref-type="bibr" rid="bib43">Robinson et al., 2011</xref>). iCLIP tags were extended to 80 nt sequences centered at the crosslinked site, and annotated within human exons using ChIPseeker v.1.32.0 (<xref ref-type="bibr" rid="bib59">Yu et al., 2015</xref>) and Ensembl Genes v.105. iCLIP tags present in mRNA exons were filtered using biomaRt v.2.52.0 (<xref ref-type="bibr" rid="bib12">Durinck et al., 2005</xref>). iCLIP-containing exons were listed once, independently of the number of tags or tag score, and filtered to isolate internal exons using the annotations from Ensembl Genes v.105. Plots were created using ggplot2 v.3.3.6. (<xref ref-type="bibr" rid="bib57">Wickham, 2016</xref>) on R v.4.2.1. Statistical analyses to compare exon length distributions between samples were performed with Wilcoxon Rank Sum and Kruskal-Wallis tests using base R stats package v.4.2.1 and pseudorank v.1.0.1 (<xref ref-type="bibr" rid="bib23">Happ et al., 2020</xref>). Significant enrichment of ultra-long exons in RBMX-regulated and bound exons was tested using the ‘N-1’ Chi-squared test (<xref ref-type="bibr" rid="bib9">Campbell, 2007</xref>) on the MedCalc Software version 20.218.</p></sec><sec id="s4-9"><title>Gene ontology analyses</title><p>Gene ontology analyses were performed in R v.4.2.1 using GOstats v.2.62.0 (<xref ref-type="bibr" rid="bib19">Falcon and Gentleman, 2007</xref>) except for [<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>] for which clusterProfiler::enrichGO v.4.4.4 (<xref ref-type="bibr" rid="bib58">Yu et al., 2012</xref>) was used. Entrez annotations were obtained with biomaRt v.2.52.0 (<xref ref-type="bibr" rid="bib12">Durinck et al., 2005</xref>). Read counts from control treated HEK293 cells (<xref ref-type="bibr" rid="bib33">Liu et al., 2017</xref>) were used to isolate genes expressed in HEK293 cells. Gene ontology analyses for <xref ref-type="fig" rid="fig3">Figure 3A</xref> were performed for ultra-long (&gt;1000 bp) exons bound or regulated by RBMX against all genes expressed in HEK293 cells that contain ultra-long exons. The Bioconductor annotation data package org.Hs.eg.db v.3.15.0 was used as background for GOBP terms. p-values were adjusted by false discovery rate using the base R stats package v.4.2.1, except for [<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>] for which the default Benjamini-Hochberg method was used while running enrichGO. Significantly enriched GOBP pathways were filtered with a p-value cut-off of 0.05. Redundant terms identified with GOstats were removed using Revigo (<xref ref-type="bibr" rid="bib48">Supek et al., 2011</xref>) with SimRel similarity measure against human genes eliminating terms with dispensability score above 0.5. The dot plots were produced using ggplot2 v.3.3.6 (<xref ref-type="bibr" rid="bib57">Wickham, 2016</xref>) focussing on representative terms associated with at least 5% of the initial gene list. Full GOBP lists can be found in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p></sec><sec id="s4-10"><title>Comet assay</title><p>The comet assay was performed using the Abcam Comet Assay kit (ab238544) according to the manufacturer’s instructions. Briefly U-2 OS cells transfected with RBMX siRNA or control siRNA were harvested after 72 hr, and 1×10<sup>5</sup> cells were mixed with cold PBS. Cells in PBS were mixed with low-melting comet agarose (1/10) and layered on the glass slides pre-coated with low-melting comet agarose. The slides were lysed in 1 X lysis buffer (pH10.0, Abcam Comet Assay kit) for 48 hr at 4 °C, immersed in Alkaline solution (300 mM NaOH, pH &gt;13, 1 mM EDTA) for 30 min at 4 °C in the dark and then electrophoresed in Alkaline Electrophoresis Solution (300 mM NaOH, pH &gt;13, 1 mM EDTA) at 300 mA, 1 volt/cm for 20 min. The slide was then washed in pre-chilled DI H2O for 2 min, fixed in 70% ethanol for 5 min, and stained with 1 X Vista Green DNA Dye (1/10000 in TE Buffer (10 mM Tris, pH 7.5, 1 mM EDTA), Abcam Comet Assay kit) for 15 min and visualised under fluorescence microscopy Zeiss AxioImager (System 3). Comet quantification was performed using OpenComet (<xref ref-type="bibr" rid="bib21">Gyori et al., 2014</xref>).</p></sec><sec id="s4-11"><title>RNA extraction and cDNA synthesis for transcript isoform analysis</title><p>RNA was extracted using standard TRIzol RNA extraction (Invitrogen, #15596026) following the manufacturer’s instructions. cDNA was synthesised from 500 ng total RNA using SuperScript VILO cDNA synthesis kit (Invitrogen #11754050) following the manufacturer’s instructions. To analyse the splicing profiles of the alternative events primers were designed using Primer 3 Plus (<xref ref-type="bibr" rid="bib51">Untergasser et al., 2012</xref>), and the predicted PCR products were confirmed using the UCSC In-Silico PCR tool. <italic>ETAA1</italic> transcript isoform containing the long exon 5 was amplified by RT-PCR using primers 5ʹ-<named-content content-type="sequence">GCTGGACATGTGGATTGGTG</named-content>-3ʹ and 5ʹ-<named-content content-type="sequence">GTGCTCCAAAAAGCCTCTGG</named-content>-3ʹ, while <italic>ETAA1</italic> transcript isoform containing the short exon 5 was amplified using primers 5ʹ-<named-content content-type="sequence">GCTGGACATGTGGATTGGTG</named-content>-3ʹ and 5ʹ-<named-content content-type="sequence">GTGGGAGCTGCATTTACAGATG</named-content>-3ʹ. RT-PCR with this second primer pair could in principle amplify also a 2313 bp product from the <italic>ETAA1</italic> transcript isoform containing the long exon 5, however, PCR conditions were chosen to selectively analyse shorter fragments. <italic>REV3L</italic> 5ʹ-<named-content content-type="sequence">TCACTGTGCAGAAATACCCAC</named-content>-3ʹ<italic>,</italic> 5ʹ-<named-content content-type="sequence">AGGCCACGTCTACAAGTTCA</named-content>-3ʹ<italic>,</italic> 5ʹ-<named-content content-type="sequence">ACATGGGAAGAAAGGGCACT</named-content>-3ʹ. <italic>ATRX</italic> 5ʹ<italic>-</italic><named-content content-type="sequence">TGAAACTTCATTTTCAACCAAATGCTC</named-content><italic>-</italic>3ʹ and 5ʹ<italic>-</italic><named-content content-type="sequence">ATCAAGGGGATGGCAGCAG</named-content>-3ʹ All PCR reactions were performed using GoTaq G2 DNA polymerase kit from Promega following the manufacturer’s instructions. All PCR products were examined using the QIAxcel capillary electrophoresis system 100 (Qiagen). Statistical analyses were performed using GraphPad Prism 9.5.0.</p></sec><sec id="s4-12"><title>Western blot analyses</title><p>Harvested cells treated with either control siRNA or siRNA against RBMX were resuspended in 100 mM Tris-HCL, 200 mM DTT, 4% SDS, 20% Glycerol, 0.2% Bromophenol blue, then sonicated (Sanyo Soniprep 150) and heated to 95 °C for 5 min. Protein separation was performed by SDS-PAGE. Proteins were then transferred to a nitrocellulose membrane, incubated in blocking buffer (5% Milk in 2.5% TBS-T), and stained with primary antibodies diluted in blocking buffer to the concentrations indicated below, at 4 °C overnight. After incubation, the membranes were washed three times with TBS-T and incubated with the secondary antibodies for 1 hr at room temperature. Detection was carried out using the Clarity Western ECL Substrate (Cytiva, RPN2232) and developed using medical X-ray film blue film in an X-ray film processor developer. The following primary antibodies were used at the concentrations indicated: anti-RBMX (Cell Signalling, D7C2V) diluted 1:1000, anti-ETAA1 (Sigma, HPA035048) diluted 1:1000, anti-Tubulin (Abcam, ab18251) diluted 1:2000, anti-GAPDH (Abcepta, P04406) diluted 1:2000, and anti-FLAG (Sigma, F1804) diluted 1:2000.</p></sec><sec id="s4-13"><title>Minigene construction and validation</title><p>A genomic region containing <italic>ETAA1</italic> <ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/exons">exon</ext-link> 5 and flanking intronic sequences were PCR amplified from human <ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/topics/neuroscience/genomic-dna">genomic DNA</ext-link> using the primers 5ʹ<italic>-</italic><named-content content-type="sequence">AAAAAAAAACAATTGAGTTAAGACTTTTCAGCTTTTCTGA</named-content>-3ʹ and 5ʹ-<named-content content-type="sequence">AAAAAAAAACAATTGAGTGCTGGGAAAGAATTCAATGT</named-content>-3ʹ and cloned into pXJ41 (<xref ref-type="bibr" rid="bib7">Bourgeois et al., 1999</xref>). Splicing patterns were monitored after <ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/transfection">transfection</ext-link> into HEK293 cells. RNA was extracted with TRIzol (Invitrogen, #15596026) and analysed using a One Step RT-PCR kit (Qiagen, #210210) following manufacturer’s instructions. RT–PCR experiments used 100 ng of RNA in a 5 μl reaction using a multiplex RT-PCR using primers: 5ʹ-<named-content content-type="sequence">GCTGGACATGTGGATTGGTG</named-content>-3ʹ, 5ʹ-<named-content content-type="sequence">GTGGGAGCTGCATTTACAGATG</named-content>-3ʹ and 5ʹ-<named-content content-type="sequence">GTGCTCCAAAAAGCCTCTGG</named-content>-3ʹ. Reactions were analysed and quantified using the QIAxcel capillary electrophoresis system 100 (Qiagen).</p></sec><sec id="s4-14"><title>Branchpoint analysis</title><p>Using the RNA from the long minigene transfections with RBMX and RBMXΔRRM, total RNA was extracted using TRIZOL reagent (Life Technologies) following the standard manufacturer’s instructions, RNA concentration was quantified by NanoDrop UV-Vis spectrophotometer and treated with DNase I (Invitrogen, Am1906). 1 μg of purified RNA was reverse transcribed with a SuperScript III Reverse Transcriptase (Invitrogen, #18080093) using ETAA1 DBR R1 RT-PCR primer 5′-<named-content content-type="sequence">AAGTTCTTCTTCTTGACTTTGTGTT</named-content>-3′ and treated with RNaseH (New England Biolabs, M0297S). 1 μl of the cDNA was used for PCR amplification reactions using using GoTaq G2 DNA Polymerase (Promega, #M7845) in the standard 25 µl reaction following the manufacturer’s instructions. PCR amplification was carried out using two different primer sets ETAA1 DBR R2 5′-<named-content content-type="sequence">GCTCTTGAATCACATCTAGCTCT</named-content>-3′ and ETAA1 DBR F1 5′-<named-content content-type="sequence">AGCCAAACTAACTCAGCAACA</named-content>-3′, ETAA1 DBR R2 5′-<named-content content-type="sequence">GCTCTTGAATCACATCTAGCTCT</named-content>-3′ and ETAA1 DBR F2 5′-<named-content content-type="sequence">AGCATTTGAATCCAGGCAGC</named-content>-3′ with 18 cycles of amplification at an annealing temperature of 56 °C. PCR products were sub-cloned into the pGEM-T-Easy vector (Promega, A1360) using manufacture instructions. Plasmids were subjected to Sanger sequencing (Source BioScience) and the sequences were checked with BioEdit (<xref ref-type="bibr" rid="bib22">Hall, 1999</xref>) and aligned to the genome with UCSC (<xref ref-type="bibr" rid="bib27">Karolchik et al., 2014</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Investigation, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Funding acquisition, Investigation, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Formal analysis</p></fn><fn fn-type="con" id="con7"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Formal analysis</p></fn><fn fn-type="con" id="con10"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con11"><p>Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Formal analysis</p></fn><fn fn-type="con" id="con14"><p>Supervision, Investigation</p></fn><fn fn-type="con" id="con15"><p>Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con16"><p>Supervision, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con17"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Project administration, Writing – review and editing, Writing – original draft</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-89705-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The data discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus (<xref ref-type="bibr" rid="bib13">Edgar et al., 2002</xref>) and are accessible through GEO series accession number <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE233498">GSE233498</ext-link>. Previously published GSE74085 data was also accessed from Gene Expression Omnibus.</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>An anciently diverged family of RNA binding proteins maintain correct splicing of ultra-long exons through cryptic splice site repression</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE233498">GSE233498</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Parisien</surname><given-names>M</given-names></name><name><surname>Dai</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>K</given-names></name><name><surname>Diatchenko</surname><given-names>L</given-names></name><name><surname>Pan</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74085">GSE74085</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) (grants BB/S008039/1, BBW002019/1, and BB/P006612/1), and by the JGW Patterson Foundation. Saad Aldalaqan was supported by a PhD studentship from the King Fahad Medical City. Chileleko Siachisumo was supported by the Newcastle Liverpool Durham BBSRC Doctoral Training Partnership (BB/M011186/1).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamson</surname><given-names>B</given-names></name><name><surname>Smogorzewska</surname><given-names>A</given-names></name><name><surname>Sigoillot</surname><given-names>FD</given-names></name><name><surname>King</surname><given-names>RW</given-names></name><name><surname>Elledge</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A genome-wide homologous recombination screen identifies the RNA-binding protein RBMX as A component of the DNA-damage response</article-title><source>Nature Cell Biology</source><volume>14</volume><fpage>318</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1038/ncb2426</pub-id><pub-id pub-id-type="pmid">22344029</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldalaqan</surname><given-names>S</given-names></name><name><surname>Dalgliesh</surname><given-names>C</given-names></name><name><surname>Luzzi</surname><given-names>S</given-names></name><name><surname>Siachisumo</surname><given-names>C</given-names></name><name><surname>Reynard</surname><given-names>LN</given-names></name><name><surname>Ehrmann</surname><given-names>I</given-names></name><name><surname>Elliott</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Cryptic splicing: common pathological mechanisms involved in male infertility and neuronal diseases</article-title><source>Cell Cycle</source><volume>21</volume><fpage>219</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1080/15384101.2021.2015672</pub-id><pub-id pub-id-type="pmid">34927545</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><data-title>FastQC - a quality control tool for high throughput sequence data</data-title><version designator="GPL v3">GPL v3</version><source>Bioinformatics</source><ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.babraham.ac.uk/projects/fastqc">http://www.bioinformatics.babraham.ac.uk/projects/fastqc</ext-link></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attig</surname><given-names>J</given-names></name><name><surname>Agostini</surname><given-names>F</given-names></name><name><surname>Gooding</surname><given-names>C</given-names></name><name><surname>Chakrabarti</surname><given-names>AM</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Haberman</surname><given-names>N</given-names></name><name><surname>Zagalak</surname><given-names>JA</given-names></name><name><surname>Emmett</surname><given-names>W</given-names></name><name><surname>Smith</surname><given-names>CWJ</given-names></name><name><surname>Luscombe</surname><given-names>NM</given-names></name><name><surname>Ule</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Heteromeric RNP assembly at LINEs controls lineage-specific RNA processing</article-title><source>Cell</source><volume>174</volume><fpage>1067</fpage><lpage>1081</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.07.001</pub-id><pub-id pub-id-type="pmid">30078707</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bass</surname><given-names>TE</given-names></name><name><surname>Luzwick</surname><given-names>JW</given-names></name><name><surname>Kavanaugh</surname><given-names>G</given-names></name><name><surname>Carroll</surname><given-names>C</given-names></name><name><surname>Dungrawala</surname><given-names>H</given-names></name><name><surname>Glick</surname><given-names>GG</given-names></name><name><surname>Feldkamp</surname><given-names>MD</given-names></name><name><surname>Putney</surname><given-names>R</given-names></name><name><surname>Chazin</surname><given-names>WJ</given-names></name><name><surname>Cortez</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>ETAA1 acts at stalled replication forks to maintain genome integrity</article-title><source>Nature Cell Biology</source><volume>18</volume><fpage>1185</fpage><lpage>1195</lpage><pub-id pub-id-type="doi">10.1038/ncb3415</pub-id><pub-id pub-id-type="pmid">27723720</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Finding splice sites within a wilderness of RNA</article-title><source>RNA</source><volume>1</volume><fpage>763</fpage><lpage>771</lpage><pub-id pub-id-type="pmid">7493322</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourgeois</surname><given-names>CF</given-names></name><name><surname>Popielarz</surname><given-names>M</given-names></name><name><surname>Hildwein</surname><given-names>G</given-names></name><name><surname>Stevenin</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Identification of a bidirectional splicing enhancer: differential involvement of SR proteins in 5’ or 3’ splice site activation</article-title><source>Molecular and Cellular Biology</source><volume>19</volume><fpage>7347</fpage><lpage>7356</lpage><pub-id pub-id-type="doi">10.1128/MCB.19.11.7347</pub-id><pub-id pub-id-type="pmid">10523623</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>T</given-names></name><name><surname>Cinkornpumin</surname><given-names>JK</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Villarreal</surname><given-names>OD</given-names></name><name><surname>Pastor</surname><given-names>WA</given-names></name><name><surname>Richard</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Deletion of RBMX RGG/RG motif in Shashi-XLID syndrome leads to aberrant p53 activation and neuronal differentiation defects</article-title><source>Cell Reports</source><volume>36</volume><elocation-id>109337</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2021.109337</pub-id><pub-id pub-id-type="pmid">34260915</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations</article-title><source>Statistics in Medicine</source><volume>26</volume><fpage>3661</fpage><lpage>3675</lpage><pub-id pub-id-type="doi">10.1002/sim.2832</pub-id><pub-id pub-id-type="pmid">17315184</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominissini</surname><given-names>D</given-names></name><name><surname>Moshitch-Moshkovitz</surname><given-names>S</given-names></name><name><surname>Schwartz</surname><given-names>S</given-names></name><name><surname>Salmon-Divon</surname><given-names>M</given-names></name><name><surname>Ungar</surname><given-names>L</given-names></name><name><surname>Osenberg</surname><given-names>S</given-names></name><name><surname>Cesarkas</surname><given-names>K</given-names></name><name><surname>Jacob-Hirsch</surname><given-names>J</given-names></name><name><surname>Amariglio</surname><given-names>N</given-names></name><name><surname>Kupiec</surname><given-names>M</given-names></name><name><surname>Sorek</surname><given-names>R</given-names></name><name><surname>Rechavi</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq</article-title><source>Nature</source><volume>485</volume><fpage>201</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1038/nature11112</pub-id><pub-id pub-id-type="pmid">22575960</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durinck</surname><given-names>S</given-names></name><name><surname>Moreau</surname><given-names>Y</given-names></name><name><surname>Kasprzyk</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>S</given-names></name><name><surname>De Moor</surname><given-names>B</given-names></name><name><surname>Brazma</surname><given-names>A</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>BioMart and Bioconductor: A powerful link between biological databases and microarray data analysis</article-title><source>Bioinformatics</source><volume>21</volume><fpage>3439</fpage><lpage>3440</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bti525</pub-id><pub-id pub-id-type="pmid">16082012</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgar</surname><given-names>R</given-names></name><name><surname>Domrachev</surname><given-names>M</given-names></name><name><surname>Lash</surname><given-names>AE</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Gene expression omnibus: NCBI gene expression and hybridization array data repository</article-title><source>Nucleic Acids Research</source><volume>30</volume><fpage>207</fpage><lpage>210</lpage><pub-id pub-id-type="doi">10.1093/nar/30.1.207</pub-id><pub-id pub-id-type="pmid">11752295</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrmann</surname><given-names>I</given-names></name><name><surname>Gazzara</surname><given-names>MR</given-names></name><name><surname>Pagliarini</surname><given-names>V</given-names></name><name><surname>Dalgliesh</surname><given-names>C</given-names></name><name><surname>Kheirollahi-Chadegani</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Cesari</surname><given-names>E</given-names></name><name><surname>Danilenko</surname><given-names>M</given-names></name><name><surname>Maclennan</surname><given-names>M</given-names></name><name><surname>Lowdon</surname><given-names>K</given-names></name><name><surname>Vogel</surname><given-names>T</given-names></name><name><surname>Keskivali-Bond</surname><given-names>P</given-names></name><name><surname>Wells</surname><given-names>S</given-names></name><name><surname>Cater</surname><given-names>H</given-names></name><name><surname>Fort</surname><given-names>P</given-names></name><name><surname>Santibanez-Koref</surname><given-names>M</given-names></name><name><surname>Middei</surname><given-names>S</given-names></name><name><surname>Sette</surname><given-names>C</given-names></name><name><surname>Clowry</surname><given-names>GJ</given-names></name><name><surname>Barash</surname><given-names>Y</given-names></name><name><surname>Cunningham</surname><given-names>MO</given-names></name><name><surname>Elliott</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A SLM2 feedback pathway controls cortical network activity and mouse behavior</article-title><source>Cell Reports</source><volume>17</volume><fpage>3269</fpage><lpage>3280</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.12.002</pub-id><pub-id pub-id-type="pmid">28009295</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ehrmann</surname><given-names>I</given-names></name><name><surname>Crichton</surname><given-names>JH</given-names></name><name><surname>Gazzara</surname><given-names>MR</given-names></name><name><surname>James</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Grellscheid</surname><given-names>SN</given-names></name><name><surname>Curk</surname><given-names>T</given-names></name><name><surname>de Rooij</surname><given-names>D</given-names></name><name><surname>Steyn</surname><given-names>JS</given-names></name><name><surname>Cockell</surname><given-names>S</given-names></name><name><surname>Adams</surname><given-names>IR</given-names></name><name><surname>Barash</surname><given-names>Y</given-names></name><name><surname>Elliott</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An ancient germ cell-specific RNA-binding protein protects the germline from cryptic splice site poisoning</article-title><source>eLife</source><volume>8</volume><elocation-id>39304</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.39304</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>DJ</given-names></name><name><surname>Millar</surname><given-names>MR</given-names></name><name><surname>Oghene</surname><given-names>K</given-names></name><name><surname>Ross</surname><given-names>A</given-names></name><name><surname>Kiesewetter</surname><given-names>F</given-names></name><name><surname>Pryor</surname><given-names>J</given-names></name><name><surname>McIntyre</surname><given-names>M</given-names></name><name><surname>Hargreave</surname><given-names>TB</given-names></name><name><surname>Saunders</surname><given-names>PTK</given-names></name><name><surname>Vogt</surname><given-names>PH</given-names></name><name><surname>Chandley</surname><given-names>AC</given-names></name><name><surname>Cooke</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Expression of RBM in the nuclei of human germ cells is dependent on a critical region of the Y chromosome long arm</article-title><source>PNAS</source><volume>94</volume><fpage>3848</fpage><lpage>3853</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.8.3848</pub-id><pub-id pub-id-type="pmid">9108067</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>DJ</given-names></name><name><surname>Bourgeois</surname><given-names>CF</given-names></name><name><surname>Klink</surname><given-names>A</given-names></name><name><surname>Stévenin</surname><given-names>J</given-names></name><name><surname>Cooke</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>A mammalian germ cell-specific RNA-binding protein interacts with ubiquitously expressed proteins involved in splice site selection</article-title><source>PNAS</source><volume>97</volume><fpage>5717</fpage><lpage>5722</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.11.5717</pub-id><pub-id pub-id-type="pmid">10823932</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname><given-names>DJ</given-names></name><name><surname>Dalgliesh</surname><given-names>C</given-names></name><name><surname>Hysenaj</surname><given-names>G</given-names></name><name><surname>Ehrmann</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>RBMX family proteins connect the fields of nuclear RNA processing, disease and sex chromosome biology</article-title><source>The International Journal of Biochemistry &amp; Cell Biology</source><volume>108</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2018.12.014</pub-id><pub-id pub-id-type="pmid">30593955</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falcon</surname><given-names>S</given-names></name><name><surname>Gentleman</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Using GOstats to test gene lists for GO term association</article-title><source>Bioinformatics</source><volume>23</volume><fpage>257</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btl567</pub-id><pub-id pub-id-type="pmid">17098774</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gooding</surname><given-names>C</given-names></name><name><surname>Clark</surname><given-names>F</given-names></name><name><surname>Wollerton</surname><given-names>MC</given-names></name><name><surname>Grellscheid</surname><given-names>SN</given-names></name><name><surname>Groom</surname><given-names>H</given-names></name><name><surname>Smith</surname><given-names>CWJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A class of human exons with predicted distant branch points revealed by analysis of AG dinucleotide exclusion zones</article-title><source>Genome Biology</source><volume>7</volume><elocation-id>R1</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2006-7-1-r1</pub-id><pub-id pub-id-type="pmid">16507133</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyori</surname><given-names>BM</given-names></name><name><surname>Venkatachalam</surname><given-names>G</given-names></name><name><surname>Thiagarajan</surname><given-names>PS</given-names></name><name><surname>Hsu</surname><given-names>D</given-names></name><name><surname>Clement</surname><given-names>MV</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>OpenComet: an automated tool for comet assay image analysis</article-title><source>Redox Biology</source><volume>2</volume><fpage>457</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1016/j.redox.2013.12.020</pub-id><pub-id pub-id-type="pmid">24624335</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Bioedit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/ NT</article-title><conf-name>Nucleic Acids Symposium Series</conf-name><pub-id pub-id-type="doi">10.14601/Phytopathol_Mediterr-14998u1.29</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Happ</surname><given-names>M</given-names></name><name><surname>Zimmermann</surname><given-names>G</given-names></name><name><surname>Brunner</surname><given-names>E</given-names></name><name><surname>Bathke</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Pseudo-ranks: how to calculate them efficiently in R</article-title><source>Journal of Statistical Software</source><volume>95</volume><elocation-id>v095.c01</elocation-id><pub-id pub-id-type="doi">10.18637/jss.v095.c01</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huppertz</surname><given-names>I</given-names></name><name><surname>Attig</surname><given-names>J</given-names></name><name><surname>D’Ambrogio</surname><given-names>A</given-names></name><name><surname>Easton</surname><given-names>LE</given-names></name><name><surname>Sibley</surname><given-names>CR</given-names></name><name><surname>Sugimoto</surname><given-names>Y</given-names></name><name><surname>Tajnik</surname><given-names>M</given-names></name><name><surname>König</surname><given-names>J</given-names></name><name><surname>Ule</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>iCLIP: protein-RNA interactions at nucleotide resolution</article-title><source>Methods</source><volume>65</volume><fpage>274</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2013.10.011</pub-id><pub-id pub-id-type="pmid">24184352</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>SP</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The DNA-damage response in human biology and disease</article-title><source>Nature</source><volume>461</volume><fpage>1071</fpage><lpage>1078</lpage><pub-id pub-id-type="doi">10.1038/nature08467</pub-id><pub-id pub-id-type="pmid">19847258</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Fan</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Khan</surname><given-names>T</given-names></name><name><surname>Hao</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Nadano</surname><given-names>D</given-names></name><name><surname>Huleihel</surname><given-names>M</given-names></name><name><surname>Lunenfeld</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>PJ</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>RPL10L is required for male meiotic division by compensating for RPL10 during Meiotic Sex chromosome inactivation in mice</article-title><source>Current Biology</source><volume>27</volume><fpage>1498</fpage><lpage>1505</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2017.04.017</pub-id><pub-id pub-id-type="pmid">28502657</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karolchik</surname><given-names>D</given-names></name><name><surname>Barber</surname><given-names>GP</given-names></name><name><surname>Casper</surname><given-names>J</given-names></name><name><surname>Clawson</surname><given-names>H</given-names></name><name><surname>Cline</surname><given-names>MS</given-names></name><name><surname>Diekhans</surname><given-names>M</given-names></name><name><surname>Dreszer</surname><given-names>TR</given-names></name><name><surname>Fujita</surname><given-names>PA</given-names></name><name><surname>Guruvadoo</surname><given-names>L</given-names></name><name><surname>Haeussler</surname><given-names>M</given-names></name><name><surname>Harte</surname><given-names>RA</given-names></name><name><surname>Heitner</surname><given-names>S</given-names></name><name><surname>Hinrichs</surname><given-names>AS</given-names></name><name><surname>Learned</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>BT</given-names></name><name><surname>Li</surname><given-names>CH</given-names></name><name><surname>Raney</surname><given-names>BJ</given-names></name><name><surname>Rhead</surname><given-names>B</given-names></name><name><surname>Rosenbloom</surname><given-names>KR</given-names></name><name><surname>Sloan</surname><given-names>CA</given-names></name><name><surname>Speir</surname><given-names>ML</given-names></name><name><surname>Zweig</surname><given-names>AS</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name><name><surname>Kuhn</surname><given-names>RM</given-names></name><name><surname>Kent</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The UCSC genome browser database: 2014 update</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>D764</fpage><lpage>D770</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt1168</pub-id><pub-id pub-id-type="pmid">24270787</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawachi</surname><given-names>T</given-names></name><name><surname>Masuda</surname><given-names>A</given-names></name><name><surname>Yamashita</surname><given-names>Y</given-names></name><name><surname>Takeda</surname><given-names>J-I</given-names></name><name><surname>Ohkawara</surname><given-names>B</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Ohno</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Regulated splicing of large exons is linked to phase-separation of vertebrate transcription factors</article-title><source>The EMBO Journal</source><volume>40</volume><elocation-id>e107485</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2020107485</pub-id><pub-id pub-id-type="pmid">34605568</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Langmead</surname><given-names>B</given-names></name><name><surname>Salzberg</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>HISAT: A fast spliced aligner with low memory requirements</article-title><source>Nature Methods</source><volume>12</volume><fpage>357</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3317</pub-id><pub-id pub-id-type="pmid">25751142</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konig</surname><given-names>J</given-names></name><name><surname>Zarnack</surname><given-names>K</given-names></name><name><surname>Rot</surname><given-names>G</given-names></name><name><surname>Curk</surname><given-names>T</given-names></name><name><surname>Kayikci</surname><given-names>M</given-names></name><name><surname>Zupan</surname><given-names>B</given-names></name><name><surname>Turner</surname><given-names>DJ</given-names></name><name><surname>Luscombe</surname><given-names>NM</given-names></name><name><surname>Ule</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>ICLIP--transcriptome-wide mapping of protein-RNA interactions with individual nucleotide resolution</article-title><source>Journal of Visualized Experiments</source><volume>01</volume><elocation-id>2638</elocation-id><pub-id pub-id-type="doi">10.3791/2638</pub-id><pub-id pub-id-type="pmid">21559008</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Královičová</surname><given-names>J</given-names></name><name><surname>Borovská</surname><given-names>I</given-names></name><name><surname>Pengelly</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>E</given-names></name><name><surname>Abaffy</surname><given-names>P</given-names></name><name><surname>Šindelka</surname><given-names>R</given-names></name><name><surname>Grutzner</surname><given-names>F</given-names></name><name><surname>Vořechovský</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Restriction of an intron size en route to endothermy</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>2460</fpage><lpage>2487</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab046</pub-id><pub-id pub-id-type="pmid">33550394</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Handsaker</surname><given-names>B</given-names></name><name><surname>Wysoker</surname><given-names>A</given-names></name><name><surname>Fennell</surname><given-names>T</given-names></name><name><surname>Ruan</surname><given-names>J</given-names></name><name><surname>Homer</surname><given-names>N</given-names></name><name><surname>Marth</surname><given-names>G</given-names></name><name><surname>Abecasis</surname><given-names>G</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name><collab>1000 Genome Project Data Processing Subgroup</collab></person-group><year iso-8601-date="2009">2009</year><article-title>The sequence alignment/map format and SAMtools</article-title><source>Bioinformatics</source><volume>25</volume><fpage>2078</fpage><lpage>2079</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id><pub-id pub-id-type="pmid">19505943</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>N</given-names></name><name><surname>Zhou</surname><given-names>KI</given-names></name><name><surname>Parisien</surname><given-names>M</given-names></name><name><surname>Dai</surname><given-names>Q</given-names></name><name><surname>Diatchenko</surname><given-names>L</given-names></name><name><surname>Pan</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>6051</fpage><lpage>6063</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx141</pub-id><pub-id pub-id-type="pmid">28334903</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>K</given-names></name><name><surname>Inglis</surname><given-names>JD</given-names></name><name><surname>Sharkey</surname><given-names>A</given-names></name><name><surname>Bickmore</surname><given-names>WA</given-names></name><name><surname>Hill</surname><given-names>RE</given-names></name><name><surname>Prosser</surname><given-names>EJ</given-names></name><name><surname>Speed</surname><given-names>RM</given-names></name><name><surname>Thomson</surname><given-names>EJ</given-names></name><name><surname>Jobling</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>K</given-names></name><name><surname>Wolfe</surname><given-names>J</given-names></name><name><surname>Cooke</surname><given-names>HJ</given-names></name><name><surname>Hargreave</surname><given-names>TB</given-names></name><name><surname>Chandley</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>A Y chromosome gene family with RNA-binding protein homology: candidates for the azoospermia factor AZF controlling human spermatogenesis</article-title><source>Cell</source><volume>75</volume><fpage>1287</fpage><lpage>1295</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(93)90616-x</pub-id><pub-id pub-id-type="pmid">8269511</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marquez</surname><given-names>Y</given-names></name><name><surname>Höpfler</surname><given-names>M</given-names></name><name><surname>Ayatollahi</surname><given-names>Z</given-names></name><name><surname>Barta</surname><given-names>A</given-names></name><name><surname>Kalyna</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Unmasking alternative splicing inside protein-coding exons defines exitrons and their role in proteome plasticity</article-title><source>Genome Research</source><volume>25</volume><fpage>995</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1101/gr.186585.114</pub-id><pub-id pub-id-type="pmid">25934563</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>SK</given-names></name><name><surname>Wood</surname><given-names>RD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>DNA polymerase ζ in DNA replication and repair</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>8348</fpage><lpage>8361</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz705</pub-id><pub-id pub-id-type="pmid">31410467</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moursy</surname><given-names>A</given-names></name><name><surname>Allain</surname><given-names>FHT</given-names></name><name><surname>Cléry</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Characterization of the RNA recognition mode of hnRNP G extends its role in SMN2 splicing regulation</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>6659</fpage><lpage>6672</lpage><pub-id pub-id-type="doi">10.1093/nar/gku244</pub-id><pub-id pub-id-type="pmid">24692659</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munschauer</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>CT</given-names></name><name><surname>Sirokman</surname><given-names>K</given-names></name><name><surname>Hartigan</surname><given-names>CR</given-names></name><name><surname>Hogstrom</surname><given-names>L</given-names></name><name><surname>Engreitz</surname><given-names>JM</given-names></name><name><surname>Ulirsch</surname><given-names>JC</given-names></name><name><surname>Fulco</surname><given-names>CP</given-names></name><name><surname>Subramanian</surname><given-names>V</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Schenone</surname><given-names>M</given-names></name><name><surname>Guttman</surname><given-names>M</given-names></name><name><surname>Carr</surname><given-names>SA</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The NORAD lncRNA assembles a topoisomerase complex critical for genome stability</article-title><source>Nature</source><volume>561</volume><fpage>132</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0453-z</pub-id><pub-id pub-id-type="pmid">30150775</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasim</surname><given-names>MT</given-names></name><name><surname>Chernova</surname><given-names>TK</given-names></name><name><surname>Chowdhury</surname><given-names>HM</given-names></name><name><surname>Yue</surname><given-names>BG</given-names></name><name><surname>Eperon</surname><given-names>IC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>HnRNP G and Tra2beta: opposite effects on splicing matched by antagonism in RNA binding</article-title><source>Human Molecular Genetics</source><volume>12</volume><fpage>1337</fpage><lpage>1348</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddg136</pub-id><pub-id pub-id-type="pmid">12761049</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patro</surname><given-names>R</given-names></name><name><surname>Duggal</surname><given-names>G</given-names></name><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Irizarry</surname><given-names>RA</given-names></name><name><surname>Kingsford</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Salmon provides fast and bias-aware quantification of transcript expression</article-title><source>Nature Methods</source><volume>14</volume><fpage>417</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4197</pub-id><pub-id pub-id-type="pmid">28263959</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robberson</surname><given-names>BL</given-names></name><name><surname>Cote</surname><given-names>GJ</given-names></name><name><surname>Berget</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Exon definition may facilitate splice site selection in RNAs with multiple exons</article-title><source>Molecular and Cellular Biology</source><volume>10</volume><fpage>84</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1128/mcb.10.1.84-94.1990</pub-id><pub-id pub-id-type="pmid">2136768</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>JT</given-names></name><name><surname>Thorvaldsdóttir</surname><given-names>H</given-names></name><name><surname>Winckler</surname><given-names>W</given-names></name><name><surname>Guttman</surname><given-names>M</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Integrative genomics viewer</article-title><source>Nature Biotechnology</source><volume>29</volume><fpage>24</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1038/nbt.1754</pub-id><pub-id pub-id-type="pmid">21221095</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shashi</surname><given-names>V</given-names></name><name><surname>Xie</surname><given-names>P</given-names></name><name><surname>Schoch</surname><given-names>K</given-names></name><name><surname>Goldstein</surname><given-names>DB</given-names></name><name><surname>Howard</surname><given-names>TD</given-names></name><name><surname>Berry</surname><given-names>MN</given-names></name><name><surname>Schwartz</surname><given-names>CE</given-names></name><name><surname>Cronin</surname><given-names>K</given-names></name><name><surname>Sliwa</surname><given-names>S</given-names></name><name><surname>Allen</surname><given-names>A</given-names></name><name><surname>Need</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The RBMX gene as a candidate for the Shashi X-linked intellectual disability syndrome</article-title><source>Clinical Genetics</source><volume>88</volume><fpage>386</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1111/cge.12511</pub-id><pub-id pub-id-type="pmid">25256757</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sibley</surname><given-names>CR</given-names></name><name><surname>Blazquez</surname><given-names>L</given-names></name><name><surname>Ule</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Lessons from non-canonical splicing</article-title><source>Nature Reviews. Genetics</source><volume>17</volume><fpage>407</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1038/nrg.2016.46</pub-id><pub-id pub-id-type="pmid">27240813</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sims</surname><given-names>D</given-names></name><name><surname>Ilott</surname><given-names>NE</given-names></name><name><surname>Sansom</surname><given-names>SN</given-names></name><name><surname>Sudbery</surname><given-names>IM</given-names></name><name><surname>Johnson</surname><given-names>JS</given-names></name><name><surname>Fawcett</surname><given-names>KA</given-names></name><name><surname>Berlanga-Taylor</surname><given-names>AJ</given-names></name><name><surname>Luna-Valero</surname><given-names>S</given-names></name><name><surname>Ponting</surname><given-names>CP</given-names></name><name><surname>Heger</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>CGAT: computational genomics analysis toolkit</article-title><source>Bioinformatics</source><volume>30</volume><fpage>1290</fpage><lpage>1291</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt756</pub-id><pub-id pub-id-type="pmid">24395753</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Sudbery</surname><given-names>I</given-names></name><name><surname>Yonchev</surname><given-names>ID</given-names></name><name><surname>Parker</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>iCLIPlib</data-title><version designator="swh:1:rev:0dd19c9b27b0d0e29a9337b4d42babfc014b54b4">swh:1:rev:0dd19c9b27b0d0e29a9337b4d42babfc014b54b4</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:973196b7ef716bf6b66ef50f889cb94910eb8c4a;origin=https://github.com/sudlab/iCLIPlib;visit=swh:1:snp:92ecfd167848d0b01a0eed56a2dfc17d3a62d9b4;anchor=swh:1:rev:0dd19c9b27b0d0e29a9337b4d42babfc014b54b4">https://archive.softwareheritage.org/swh:1:dir:973196b7ef716bf6b66ef50f889cb94910eb8c4a;origin=https://github.com/sudlab/iCLIPlib;visit=swh:1:snp:92ecfd167848d0b01a0eed56a2dfc17d3a62d9b4;anchor=swh:1:rev:0dd19c9b27b0d0e29a9337b4d42babfc014b54b4</ext-link></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Supek</surname><given-names>F</given-names></name><name><surname>Bošnjak</surname><given-names>M</given-names></name><name><surname>Škunca</surname><given-names>N</given-names></name><name><surname>Šmuc</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>REVIGO summarizes and visualizes long lists of gene ontology terms</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e21800</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0021800</pub-id><pub-id pub-id-type="pmid">21789182</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trincado</surname><given-names>JL</given-names></name><name><surname>Entizne</surname><given-names>JC</given-names></name><name><surname>Hysenaj</surname><given-names>G</given-names></name><name><surname>Singh</surname><given-names>B</given-names></name><name><surname>Skalic</surname><given-names>M</given-names></name><name><surname>Elliott</surname><given-names>DJ</given-names></name><name><surname>Eyras</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>SUPPA2: fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions</article-title><source>Genome Biology</source><volume>19</volume><elocation-id>40</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-018-1417-1</pub-id><pub-id pub-id-type="pmid">29571299</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>JMA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Meiotic Silencing in Mammals</article-title><source>Annual Review of Genetics</source><volume>49</volume><fpage>395</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1146/annurev-genet-112414-055145</pub-id><pub-id pub-id-type="pmid">26631513</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Untergasser</surname><given-names>A</given-names></name><name><surname>Cutcutache</surname><given-names>I</given-names></name><name><surname>Koressaar</surname><given-names>T</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Faircloth</surname><given-names>BC</given-names></name><name><surname>Remm</surname><given-names>M</given-names></name><name><surname>Rozen</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Primer3--new capabilities and interfaces</article-title><source>Nucleic Acids Research</source><volume>40</volume><elocation-id>e115</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gks596</pub-id><pub-id pub-id-type="pmid">22730293</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Nostrand</surname><given-names>EL</given-names></name><name><surname>Freese</surname><given-names>P</given-names></name><name><surname>Pratt</surname><given-names>GA</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>R</given-names></name><name><surname>Blue</surname><given-names>SM</given-names></name><name><surname>Chen</surname><given-names>J-Y</given-names></name><name><surname>Cody</surname><given-names>NAL</given-names></name><name><surname>Dominguez</surname><given-names>D</given-names></name><name><surname>Olson</surname><given-names>S</given-names></name><name><surname>Sundararaman</surname><given-names>B</given-names></name><name><surname>Zhan</surname><given-names>L</given-names></name><name><surname>Bazile</surname><given-names>C</given-names></name><name><surname>Bouvrette</surname><given-names>LPB</given-names></name><name><surname>Bergalet</surname><given-names>J</given-names></name><name><surname>Duff</surname><given-names>MO</given-names></name><name><surname>Garcia</surname><given-names>KE</given-names></name><name><surname>Gelboin-Burkhart</surname><given-names>C</given-names></name><name><surname>Hochman</surname><given-names>M</given-names></name><name><surname>Lambert</surname><given-names>NJ</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>McGurk</surname><given-names>MP</given-names></name><name><surname>Nguyen</surname><given-names>TB</given-names></name><name><surname>Palden</surname><given-names>T</given-names></name><name><surname>Rabano</surname><given-names>I</given-names></name><name><surname>Sathe</surname><given-names>S</given-names></name><name><surname>Stanton</surname><given-names>R</given-names></name><name><surname>Su</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Yee</surname><given-names>BA</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Louie</surname><given-names>AL</given-names></name><name><surname>Aigner</surname><given-names>S</given-names></name><name><surname>Fu</surname><given-names>X-D</given-names></name><name><surname>Lécuyer</surname><given-names>E</given-names></name><name><surname>Burge</surname><given-names>CB</given-names></name><name><surname>Graveley</surname><given-names>BR</given-names></name><name><surname>Yeo</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A large-scale binding and functional map of human RNA-binding proteins</article-title><source>Nature</source><volume>583</volume><fpage>711</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2077-3</pub-id><pub-id pub-id-type="pmid">32728246</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaquero-Garcia</surname><given-names>J</given-names></name><name><surname>Barrera</surname><given-names>A</given-names></name><name><surname>Gazzara</surname><given-names>MR</given-names></name><name><surname>González-Vallinas</surname><given-names>J</given-names></name><name><surname>Lahens</surname><given-names>NF</given-names></name><name><surname>Hogenesch</surname><given-names>JB</given-names></name><name><surname>Lynch</surname><given-names>KW</given-names></name><name><surname>Barash</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A new view of transcriptome complexity and regulation through the lens of local splicing variations</article-title><source>eLife</source><volume>5</volume><elocation-id>e11752</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.11752</pub-id><pub-id pub-id-type="pmid">26829591</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaquero-Garcia</surname><given-names>J</given-names></name><name><surname>Aicher</surname><given-names>JK</given-names></name><name><surname>Jewell</surname><given-names>S</given-names></name><name><surname>Gazzara</surname><given-names>MR</given-names></name><name><surname>Radens</surname><given-names>CM</given-names></name><name><surname>Jha</surname><given-names>A</given-names></name><name><surname>Norton</surname><given-names>SS</given-names></name><name><surname>Lahens</surname><given-names>NF</given-names></name><name><surname>Grant</surname><given-names>GR</given-names></name><name><surname>Barash</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>RNA splicing analysis using heterogeneous and large RNA-seq datasets</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>1230</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-36585-y</pub-id><pub-id pub-id-type="pmid">36869033</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venables</surname><given-names>JP</given-names></name><name><surname>Elliott</surname><given-names>DJ</given-names></name><name><surname>Makarova</surname><given-names>OV</given-names></name><name><surname>Makarov</surname><given-names>EM</given-names></name><name><surname>Cooke</surname><given-names>HJ</given-names></name><name><surname>Eperon</surname><given-names>IC</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>RBMY, a probable human spermatogenesis factor, and other hnRNP G proteins interact with Tra2beta and affect splicing</article-title><source>Human Molecular Genetics</source><volume>9</volume><fpage>685</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1093/hmg/9.5.685</pub-id><pub-id pub-id-type="pmid">10749975</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>X chromosomes, retrogenes and their role in male reproduction</article-title><source>Trends in Endocrinology and Metabolism</source><volume>15</volume><fpage>79</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2004.01.007</pub-id><pub-id pub-id-type="pmid">15036254</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wickham</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><source>Ggplot2 elegant graphics for data analysis (use R!)</source><publisher-name>Springer</publisher-name><pub-id pub-id-type="doi">10.1007/978-0-387-98141-3</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>LG</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>QY</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>clusterProfiler: an R Package for comparing biological themes among gene clusters</article-title><source>OMICS</source><volume>16</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>LG</given-names></name><name><surname>He</surname><given-names>QY</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization</article-title><source>Bioinformatics</source><volume>31</volume><fpage>2382</fpage><lpage>2383</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv145</pub-id><pub-id pub-id-type="pmid">25765347</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarnegar</surname><given-names>BJ</given-names></name><name><surname>Flynn</surname><given-names>RA</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Do</surname><given-names>BT</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name><name><surname>Khavari</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>irCLIP platform for efficient characterization of protein-RNA interactions</article-title><source>Nature Methods</source><volume>13</volume><fpage>489</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3840</pub-id><pub-id pub-id-type="pmid">27111506</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Peng</surname><given-names>D</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>RBMX is required for activation of ATR on repetitive DNAs to maintain genome stability</article-title><source>Cell Death and Differentiation</source><volume>27</volume><fpage>3162</fpage><lpage>3176</lpage><pub-id pub-id-type="doi">10.1038/s41418-020-0570-8</pub-id><pub-id pub-id-type="pmid">32494026</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>KI</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Lyu</surname><given-names>R</given-names></name><name><surname>Wylder</surname><given-names>AC</given-names></name><name><surname>Matuszek</surname><given-names>Ż</given-names></name><name><surname>Pan</surname><given-names>JN</given-names></name><name><surname>He</surname><given-names>C</given-names></name><name><surname>Parisien</surname><given-names>M</given-names></name><name><surname>Pan</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Regulation of Co-transcriptional Pre-mRNA Splicing by m<sup>6</sup>A through the Low-Complexity Protein hnRNPG</article-title><source>Molecular Cell</source><volume>76</volume><fpage>70</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.07.005</pub-id><pub-id pub-id-type="pmid">31445886</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89705.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ron</surname><given-names>David</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of Cambridge</institution><country>United Kingdom</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This <bold>important</bold> paper addresses the process by which cryptic splice sites that occur randomly in exons are ignored by the splicing machinery. Integrating state-of- the-art genome-wide approaches such as CLIP-seq with the study of individual examples, this study <bold>convincingly</bold> implicates members of RBMX family of RNA binding proteins in such cryptic splice site suppression and showcases its importance for the fidelity of expression of genes with very large exons.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89705.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The article by Siachisumo, Luzzi and Aldalaquan et al. describes studies of RBMX and its role in maintaining proper splicing of ultra-long exons. They combine CLIP, RNA-seq, and individual example validations with manipulation of RBMX and its family members RBMY and RBMXL2 to show that the RBMX family plays a key role in maintaining proper splicing of these exons.</p><p>I think one of the main strengths of the manuscript is its ability to explore a unique but interesting question (splicing of ultra-long exons), and derive a relatively simple model from the resulting genomics data. The results shown are quite clean, suggesting that RBMX plays an important role in proper regulation of these exons. The ability of family members to rescue this phenotype (as well as only particular domains) is also quite intriguing and suggests that the mechanisms for keeping these exons properly spliced may be a quite important and highly conserved mechanism.</p><p>The revised manuscript addresses many of my earlier critiques and does an effective job of arguing that RBMX plays a large-scale role in regulating splicing of long exons. I think there are obvious open questions for future work (the mechanism of how RBMX/RBMXL2 achieve this splicing control is perhaps hinted at but not fully explored here), but I think the article provides an intriguing analysis of the role of RBMX that will activate interesting future studies.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89705.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>One of the greatest challenges for the spliceosome is to be able to repress the many cryptic splice sites that can occur in both the intronic and exotic sequences of genes. Although many studies have focused on cryptic signals in introns (because of their common involvement in disease) the question still remained open as to the factors that repress cryptic exons in exons. Because exons are normally much shorter than introns, in many cases the problem does not exist. However, in human genes a significant proportion of exons can be considerably longer than the average 150 nt length and this raises the question of how cryptic splicing can be prevented in long exons. To address this question, the authors have focused on the possible role played by an ancient mammalian RBD protein called RBMX. Using a combination of high-throughput and classic splicing methodologies, they have shown that there is a class of RBMX-dependent ultra-long exons connected where the RBMX, RBMXL2 and RBMY paralogs have closely related functional activity in repressing cryptic splice site selection.</p><p>Strengths:</p><p>In general, the present work sheds light on what has been a rather understudied process in splicing research. The use of iCLIP and RNA-seq data has not only allowed to identify the long exons where cryptic splicing is prevented by the RBMX proteins but has also allowed to identify a network of genes mostly involved in genome stability and transcriptional control where these proteins seem to play a prominent role. This can therefore also shed additional information on the way splicing has shaped evolutionary processes in the mammalian lineage and will therefore be of interest to many researchers in this field.</p><p>Weaknesses:</p><p>There are no major weaknesses, although some specific aspects of the findings could be addressed more in-depth in the recommendations to authors.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89705.3.sa3</article-id><title-group><article-title>Reviewer #3 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The manuscript by Siachisumo et al builds upon a previous publication from the same group of collaborators that showed that depletion of mouse RBMXL2 leads to a block in spermatogenesis associated with mis-splicing, particularly of large exons in genes associated with genome stability (Ehrmann et al Elife 2019). RBMXL2 is an RNA-binding protein and an autosomal retrotransposed paralog of the X-chromosomally encoded RBMX. RBMXL2 is expressed during meiosis when RBMX and the more distantly related RBMY (on the Y chromosome) are silenced. It is therefore an appealing hypothesis that RBMXL2 might provide cover for RBMX function during meiosis. To address this hypothesis the authors analysed the transcriptomic consequences of RBMX depletion by RNA-Seq in human cells (MDA-MB-231 and existing RNA-Seq data from HEK293 cells), complemented by iCLIP to analyze the binding targets of FLAG-tagged RBMX in HEK293 cells. The findings convincingly demonstrate that - like RBMXL2 - RBMX mainly acts as a splicing repressor and that it particularly acts to protect the integrity of very long (&quot;ultra-long&quot;) exons, defined as those over 1000 nt. Upon RBMX depletion, many of these exons are shortened due to the use of cryptic 5' and/or 3' splice sites. Moreover, affected genes are particularly enriched for functions associated with genome integrity - indeed &quot;comet assays&quot; show that RBMX depletion leads to DNA damage defects. Strikingly, RNA-Seq analysis showed that overexpression of RBMXL2 is able to complement the majority of splicing changes caused by RBMX depletion, particularly those involving ultra-long exons. In a smaller scale experiment RBMY was also able to complement effects of RBMX knockdown upon three target events in the ETAA1, REV3L and ATRX genes.</p><p>In addition to these core findings the manuscript also includes some experiments that begin to address more mechanistic questions, such as the potential for RBMX to sterically block access of spliceosome components to splice site elements, and preliminary structure-function analyses of RBMX showing that its RRM domain is not necessary for splicing regulatory activity on the ETAA1, REV3L and ATRX target events.</p><p>In summary, this manuscript provides clear and convincing evidence to support the role of RBMX in somatic cells as a repressor of cryptic splice sites in ultra-long exons, mirroring the function of RBMXL2 in meiotic cells. It therefore demonstrates how the RBMX/RBMXL2/RBMY family perform a key role in protecting the transcriptomic integrity of ultra-long exons.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.89705.3.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Siachisumo</surname><given-names>Chileleko</given-names></name><role specific-use="author">Author</role><aff><institution>Newcastle University</institution><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Luzzi</surname><given-names>Sara</given-names></name><role specific-use="author">Author</role><aff><institution>Newcastle University</institution><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Aldalaqan</surname><given-names>Saad</given-names></name><role specific-use="author">Author</role><aff><institution>Newcastle University</institution><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Hysenaj</surname><given-names>Gerald</given-names></name><role specific-use="author">Author</role><aff><institution>Newcastle University</institution><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Dalgliesh</surname><given-names>Caroline</given-names></name><role specific-use="author">Author</role><aff><institution>Newcastle University</institution><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Cheung</surname><given-names>Kathleen</given-names></name><role specific-use="author">Author</role><aff><institution>Newcastle University</institution><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Gazzara</surname><given-names>Matthew R</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Phildelphia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Yonchev</surname><given-names>Ivaylo D</given-names></name><role specific-use="author">Author</role><aff><institution>University of Sheffield</institution><addr-line><named-content content-type="city">Sheffield</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>James</surname><given-names>Katherine</given-names></name><role specific-use="author">Author</role><aff><institution>Newcastle University</institution><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Kheirollahi Chadegani</surname><given-names>Mahsa</given-names></name><role specific-use="author">Author</role><aff><institution>Newcastle University</institution><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Ehrmann</surname><given-names>Ingrid E</given-names></name><role specific-use="author">Author</role><aff><institution>Newcastle University</institution><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Smith</surname><given-names>Graham R</given-names></name><role specific-use="author">Author</role><aff><institution>Newcastle University</institution><addr-line><named-content content-type="city">Newcastle upon Tyne</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Cockell</surname><given-names>Simon J</given-names></name><role specific-use="author">Author</role><aff><institution>Newcastle University</institution><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Munkley</surname><given-names>Jennifer</given-names></name><role specific-use="author">Author</role><aff><institution>Newcastle University</institution><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Wilson</surname><given-names>Stuart A</given-names></name><role specific-use="author">Author</role><aff><institution>University of Sheffield</institution><addr-line><named-content content-type="city">Sheffield</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Barash</surname><given-names>Yoseph</given-names></name><role specific-use="author">Author</role><aff><institution>University of Pennsylvania</institution><addr-line><named-content content-type="city">Philadephia</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Elliott</surname><given-names>David J</given-names></name><role specific-use="author">Author</role><aff><institution>Newcastle University</institution><addr-line><named-content content-type="city">Newcastle</named-content></addr-line><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p>(1) The conclusions in the text are very broad and general but often based on a limited number of examples. It would be important that the authors hit the appropriate tone when most of the analysis (in Figure 5) is derived from n=3 events.</p></disp-quote><p>We have tried to hit the correct tone here by modifying our manuscript text. In particular we have we have added a pie chart to Figure 4 (Figure 4C, that summarises data from all RBMX targets, not just the original n=3, and shows that most RBMX targets are rescued by RBMXL2).</p><disp-quote content-type="editor-comment"><p>(2) The fractions of long/ultra-long exons actually bound by/regulated by RBMX are not clearly stated - which is in contrast to the general statement of the title (implying a global role for RBMX in proper splicing of ultra-long exons).</p></disp-quote><p>(i) We have changed our title (now “An anciently diverged family of RNA binding proteins maintain correct splicing of a class of ultra-long exons through cryptic splice site repression”).</p><p>(ii) We also include much more clear text about the fractions of long/ultralong exons bound by RBMX with the following text:</p><p>“…..This led us to test whether RBMX protein is preferentially associated with long exons. For this we plotted the distribution of internal exons bound and regulated by RBMX together with all internal exons expressed from HEK293 mRNA genes (Liu et al., 2017) (Figure 2 – Source Data 1). We found that RBMX controls and binds two different classes of exons: the first have comparable length to the average HEK293 exon, while the second were extremely long, exceeding 1000 bp in length (Figure 2F). We defined this second class as ‘ultra-long exons’, which represented the 18.9% of internal exons regulated by RBMX and 17.6% of the ones that contained RBMX iCLIP tags. These proportions were significantly enriched compared to the general abundance of internal ultra-long exons expressed from HEK293 cells, which was only 0.4% (Figure 2G)……”</p><p>“…….We next wondered whether ultra-long exons regulated by RBMX (which represented 11.6% of all ultra-long internal exons from genes expressed in HEK293) had any particular feature compared to ultra-long exons that were RBMX-independent……..”</p><disp-quote content-type="editor-comment"><p>(3) The authors should state what fraction of ultra-long exons show cryptic splicing in the RBMX siRNA that are corrected by RBMXL2 overexpression (rather than just showing the 3 events). There's some confusion about the global nature of the conclusions relative to the data displayed.</p></disp-quote><p>This is a good point. We have used the RNAseq information as suggested, and included a pie chart (Figure 4C) that includes this information.</p><disp-quote content-type="editor-comment"><p>(4) It would be helpful if the authors could identify if there are some motifs more present in ultra-long exons than others.</p></disp-quote><p>Good point, we have included k-mer analysis of the ultra-long exons bound by RBMX, and also more generally ultra-long exons in the human genome, in Figure 2H and 2I. We also add the following text:</p><p>K-mer analyses also showed that while ultra-long exons within mRNAs are rich in AT-rich sequences compared to shorter exons (Figure 2H), the ultra-long exons that are either regulated or bound by RBMX displayed enrichment of AG-rich sequences (Figure 2I), consistent with our identified RBMX-recognised sequences (Figure 2C).</p><disp-quote content-type="editor-comment"><p>(5) The authors should evaluate if RBMX-repressed 3' splice sites have similar or low splice site scores/strengths than natural 3' splice sites.</p></disp-quote><p>We have added splice site score analyses in Figure 1F and Figure 1 Supplement 1B. These show that the cryptic splice sites repressed by RBMX are not significantly different from those that are normally used. We add the following text to accompany these figure panels:</p><p>“Furthermore, analysis of splice site strength revealed that, unlike splice sites activated by RBMX (Figure 1 – Figure supplement 1B), alternative splice sites repressed by RBMX have comparable strength to more commonly used splice sites (Figure 1F). This means that RBMX operates as a splicing repressor in human somatic cells to prevent use of ‘decoy’ splice sites that could disrupt normal patterns of gene expression.”</p><disp-quote content-type="editor-comment"><p>(6) The section &quot;RBMX protein-RNA interactions may insulate important splicing signals from the spliceosome.&quot; is a very preliminary look at possible mechanisms. Can you integrate the RNA Seq and CLIP datasets to generate &quot;splicing maps&quot; that would provide more generalized insights? In fact, where possible, it would be great to integrate the iCLIP data from the same cell types to generate RNA splicing maps (with the KD RNA-seq data)</p></disp-quote><p>We have added “RNA map-type” plots to integrate iCLIP data with splicing patterns (Figure 2 Figure supplement 1D and 1E), and made corresponding changes to the text.</p><p>Additional changes</p><p>We also made some extra changes to respond to the further points raised by reviewers.</p><p>(1) We have carried out gene ontology analysis of those genes that contain RBMX-regulated ultra-long exons versus all ultra-long exons (now Figure 3A, and also Figure 3- Figure supplement 1A and 1B).</p><p>(2) We have corrected the cartoon summarising the branch point analysis (now Figure 3 – Figure Supplement 2F).</p></body></sub-article></article>